Comprehensive Physiology Wiley Online Library
For Librarians For Authors Editors About

Pharmacology of drugs acting on gastrointestinal motility

Edwin E. Daniel, Stephen M. Collins, Jo‐Ann E. T. Fox, Jan D. Huizinga

10.1002/cphy.cp060119

Source: Supplement 16: Handbook of Physiology, The Gastrointestinal System, Motility and Circulation

Originally published: 1989

Published online: January 2011

Full Article on Wiley Online Library



Abstract

The sections in this article are:

1 Nature and Classification of Receptors
1.1 Basis of Classification
1.2 Functional Studies of Receptors
1.3 Ligand Binding Studies of Receptors
1.4 Problems in Locus, Classification, and Functional Coupling of Receptors
1.5 Methods of Quantitation of Drug‐Receptor Responses
2 Agents that Act Directly on Postreceptor Mechanisms
3 Isolated Smooth Muscle Cell Preparations for Studying Pharmacology of Gastrointestinal Motility
4 Muscarinic Receptors
4.1 Muscarinic Receptor Subtypes
4.2 Locus of Action of Muscarinic Receptors
4.3 Modulation of Muscarinic Receptor
4.4 Muscarinic Postreceptor Events
4.5 Therapeutic Application of Muscarinic Pharmacology
5 Adrenergic Receptors and Gut Motility
5.1 Sympathetic Pathways
5.2 Functions of Adrenergic Innervation
5.3 Receptor Classification
5.4 Postreceptor Mechanisms
5.5 β‐Adrenoceptor‐Mediated Mechanisms
6 Serotonin Receptors and Gut Motility
6.1 Introduction
6.2 Locus and Function of Serotonin Nerves
6.3 Classification of Serotonin Receptors
6.4 Direct Action on Smooth Muscle
6.5 Actions of Serotonin on Enteric Nerves
6.6 Therapeutic Considerations
7 Purinergic Receptors and Gut Motility
7.1 Possible Functions of Purinergic Substances
7.2 Role of Purinergic Substances in Nonadrenergic Inhibition of Gut
7.3 Postsynaptic Activity
7.4 Presynaptic Activity
7.5 Classification
7.6 Mechanisms of Postsynaptic Activity
Figure 1. Figure 1.

Contraction and binding to gastric smooth muscle preparations by carbachol. Relationships between ability of muscarinic agonist carbachol to induce contraction of isolated muscle cells (open circles) and to increase frequency (open triangles) and amplitude (open inverted triangles) of phasic contraction of muscle strips from canine gastric corpus circular muscle. Data are compared with abilities of carbachol to inhibit [3H]quinuclidinyl benzilate (QNB) binding to muscle cells (closed circles) and plasma membranes (closed triangles) prepared from circular muscle of canine gastric corpus.

Adapted from Collins and Crankshaw 110,111,113
Figure 2. Figure 2.

Muscarinic receptors are located on extrinsic nerves of parasympathetic [A 205,350] and sympathetic [B 75] nervous systems. They are also located on myenteric ganglia [C 259,313], cholinergic inhibitory nerves [D1 122,256,260,313,370,410], adrenergic inhibitory nerves [D2 18,293], and noncholinergic, nonadrenergic inhibitory nerves [D3 205,206,350] of intrinsic nervous system, as well as on smooth muscle [E 113,379]. (+), Indicates excitatory or facilitatory muscarinic receptor; (−), indicates inhibitory muscarinic receptor.


Figure 1.

Contraction and binding to gastric smooth muscle preparations by carbachol. Relationships between ability of muscarinic agonist carbachol to induce contraction of isolated muscle cells (open circles) and to increase frequency (open triangles) and amplitude (open inverted triangles) of phasic contraction of muscle strips from canine gastric corpus circular muscle. Data are compared with abilities of carbachol to inhibit [3H]quinuclidinyl benzilate (QNB) binding to muscle cells (closed circles) and plasma membranes (closed triangles) prepared from circular muscle of canine gastric corpus.

Adapted from Collins and Crankshaw 110,111,113


Figure 2.

Muscarinic receptors are located on extrinsic nerves of parasympathetic [A 205,350] and sympathetic [B 75] nervous systems. They are also located on myenteric ganglia [C 259,313], cholinergic inhibitory nerves [D1 122,256,260,313,370,410], adrenergic inhibitory nerves [D2 18,293], and noncholinergic, nonadrenergic inhibitory nerves [D3 205,206,350] of intrinsic nervous system, as well as on smooth muscle [E 113,379]. (+), Indicates excitatory or facilitatory muscarinic receptor; (−), indicates inhibitory muscarinic receptor.

References
 1. Abdel‐Latif, A. A. Calcium‐mobilizing receptors, polyphos‐phoinositides, and the generation of second messengers. Pharmacol. Rev. 39: 227–272, 1986.
 2. Ablad, B., K. O. Borg, E. Carlsson, G. Johnsson, T. Malnifors, and A. G. Regardh. Animal and human pharmacological studies on metoprolol—a new selective adrenergic β1 receptor antagonist. Acta Pharmacol. Toxicol. Suppl. V: 1–44, 1975.
 3. Abrahamsson, H., and G. Dotevall. Effects of propranolol on colonic pressure in patients with irritable bowel syndrome. Scand. J. Gastroenterol. 16: 1021–1024, 1981.
 4. Abrahamsson, H., and H. Glise. Sympathetic nervous control of gastric motility and interaction with vagal activity. Scand. J. Gastroenterol. Suppl. 89: 83–88, 1984.
 5. Abrahamsson, J. Studies on the inhibitory nervous control of gastric motility. Acta Physiol. Scand. Suppl. 390: 1–38, 1973.
 6. Adams, P. R., D. A. Brown, and A. Constanti. Pharmacological inhibition of the M‐current. J. Physiol. Lond. 332: 223–262, 1982.
 7. Ahlman, H., A. Dahlström, K. Grönstad, L. E. Tisell, K. Obert, M. J. Zinner, and B. M. Jaffe. The pentagastrin test in the diagnosis of the carcinoid syndrome. Ann. Surg. 18: 65–93, 1986.
 8. Ahlquist, R. P. A study of the adrenotropic receptors. Am. J. Physiol. 153: 586–600, 1948.
 9. Ahlquist, R. P., and B. Levy. Adrenergic receptive mechanism of canine ileum. J. Pharmacol. Exp. Ther. 127: 146–149, 1959.
 10. Ahmad, S., I. Berezin, J. P. Vincent, and E. E. Daniel. Neurotensin receptors in canine intestinal smooth muscle: preparation of plasma membranes and characterization of 125I‐Tyr3‐neurotensin binding. Biochim. Biophys. Acta 896: 224–238, 1987.
 11. Aicken, C. C. Direct measurement of intracellular pH and buffering power in smooth muscle cells of guinea pig vas deferens. J. Physiol. Lond. 349: 571–585, 1984.
 12. Aicken, C. C. The effect of Na+ and Cl− on recovery from an acid load in the smooth muscle of guinea pig ureter (Abstract). J. Physiol. Lond. 369: 80P, 1985.
 13. Aicken, C. C., and A. F. Brading. Measurement of intracellular chloride in guinea pig vas deferens by ion analysis, 36Cl efflux and microelectrodes. J. Physiol. Lond. 326: 139–154, 1982.
 14. Aicken, C. C., and A. F. Brading. Towards an estimate of chloride permeability in the smooth muscle of guinea pig vas deferens. J. Physiol. Lond. 336: 179–197, 1983.
 15. Aicken, C. C., and A. F. Brading. The role of chloride‐bicarbonate exchange in the regulation of intracellular chloride in guinea pig vas deferens. J. Physiol. Lond. 349: 587–606, 1984.
 16. Aicken, C. C., and A. F. Brading. The effects of bicarbonate and foreign anions on chloride transport in smooth muscle of the guinea pig vas deferens. J. Physiol. Lond. 366: 267–280, 1985.
 17. Aicken, C. C., and N. A. Vermue. Microelectrode measurement of intracellular chloride activity in smooth muscle cells of guinea pig ureter. Pfluegers Arch. 397: 25–28, 1983.
 18. Akera, T., Y. C. Ng, I. S. Shieh, E. Bero, T. M. Brody, and W. E. Barsettin. Effects of K+ on the interaction between cardiac glycosides and Na, K‐ATPase. Eur. J. Pharmacol. 111: 147–157, 1985.
 19. Alabaster, V. A., R. F. Keir, and C. J. Peters. Comparison of potency of α2‐adrenoceptor antagonists in vitro: evidence for heterogeneity of α receptors. Br. J. Pharmacol. 88: 607–614, 1986.
 20. Alberts, P., and L. Stjarne. Facilitation, and muscarinic and α‐adrenergic inhibition of the secretion of [3H]acetylcholine and [3H]noradrenaline from guinea pig ileum myenteric nerve terminals. Acta Physiol. Scand. 116: 83–92, 1982.
 21. Allescher, H.‐D., S. Ahmad, and E. E. Daniel. Demonstration and characterization of opioid binding sites from dog small intestinal circular muscle (Abstract). Gastroenterology 92: 1295, 1987.
 22. Altaparmakov, I. A. Sympathetic control of gastric motility. Scared. J. Gastroenterol. Suppl. 89: 71–76, 1984.
 23. Altaparmakov, I. A., J. F. Erckenbrecht, and M. Wienbeck. Modulation of the adrenergic system in the treatment of postoperative bowel atonia. Scand. J. Gastroenterol. 19: 1104–1106, 1984.
 24. Amidon, G. L., and C. K. Buckner. A theoretical model for the use of functional antagonism to estimate dissociation constants for agonists. J. Pharmacol. Methods 7: 173–178, 1982.
 25. Anderson, W. B., and D. S. Salomon. Calcium, phospho‐lipid‐dependent protein kinase C. as a cellular receptor for phorbol ester tumor promoters: possible role in modulating cell growth and tumor promotion. In: Phospholipids and Cellular Regulation, edited by J. F. Kuo. Boca Raton, FL: CRC, 1985, vol. 2, p. 127–170.
 26. Anderson, R. G. G. Cyclic AMP and calcium ions in mechanical and metabolic responses of smooth muscles; influences of some hormones and drugs. Acta Physiol. Scand. Suppl. 382: 1–59, 1972.
 27. Andersson, R. G. G. Relationship between cyclic AMP phosphodiesterase activity, calcium and contraction in intestinal smooth muscle. Acta Physiol. Scand. 87: 348–358, 1973.
 28. Andersson, R. G. G., K. Nilsson, J. Wikberg, S. Johansson, and L. Lundholm. Cyclic nucleotides and the contraction of smooth muscle. Adv. Cyclic Nucleotide Res. 5: 491–518, 1975.
 29. Andersson, S., S. Rosell, U. Hjelmquist, D. Chang, and K. Folkers. Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin. Acta Physiol. Scand. 100: 231–235, 1977.
 30. Apperley, G. H., G. M. Drew, and A. T. Sullivan. Prenalterol is an agonist at β2 as well as β1 adrenoceptors. Eur. J. Pharmacol. 81: 659–663, 1982.
 31. Ariens, E. J., J. M. Van Rossum, and P. C. Koopman. Receptor reserve and threshold phenomena. 1. Theory and experiments with autonomic drugs tested on isolated organs. Arch. Int. Pharmacodyn. Ther. 127: 459–478, 1960.
 32. Aronstam, R. S., D. J. Triggle, and M. E. Eldefrawi. Structural and stereochemical requirements for muscarinic receptor binding. Mol. Pharmacol. 15: 227–235, 1979.
 33. Baer, H. P., and R. Frew. Relaxation of guinea pig fundic strip by adenosine, adenosine triphosphate and electrical stimulation: lack of antagonism by theophylline or ATP treatment. Br. J. Pharmacol. 67: 293–299, 1979.
 34. Baer, H. P., and M. J. Müller. Adenosine receptors in smooth muscle (Abstract). In: Regulatory Function of Adenosine, edited by R. M. Berne, T. L. W. Rail, and R. Rubio. The Hauge: Nijkoff, 1983, p. 500.
 35. Baer, H. P., and R. Vriend. Measurement of adenosine metabolism and uptake in smooth muscle and effects of adenosine transport inhibitors. J. Pharmacol. Exp. Ther. 229: 564–570, 1984.
 36. Bagby, R. F., A. M. Young, R. S. Dotson, B. A. Fisher, and K. McKinnon. Contraction of single smooth muscle cells from Bufo marinus stomach. Nature Lond. 234: 351–352, 1971.
 37. Barlow, R. B., K. J. Berry, P. Gleton, N. M. Nickolao, and K. S. Soh. A comparison of affinity constants for muscarine‐sensitive receptors in guinea pig arterial pacemaker cells at 29°C and in the ileum at 29°C and 37°C. Br. J. Pharmacol. 58: 613–620, 1976.
 38. Barlow, R. B., and M. Chan. The effects of pH on the affinity of pirenzepine for muscarinic receptors in the guinea pig ileum and rat fundus strip. Br. J. Pharmacol. 77: 559–563, 1982.
 39. Barrett, V. J., P. Leff, G. R. Martin, and P. J. Richardson. Pharmacological analysis of the interaction between Bay K 8644 and 5‐HT in rabbit aorta. Br. J. Pharmacol. 87: 487–494, 1986.
 40. Bean, B. P., M. Sturek, A. Puga, and K. Hermsmeyer. Calcium channels in muscle cells isolated from rat mesenteric arteries. Modulation by dihydropyridine drugs. Circ. Res. 59: 229–235, 1986.
 41. Bech, K., C. P. Hovendal, F. Gottrup, and D. Andersen. Dopaminergic and β‐adrenergic effects on gastric antral motility. Scand. J. Gastroenterol. Suppl. 89: 65–70, 1984.
 42. Behar, J., M. Kerstein, and P. Biancani. Neural control of LES closure (Abstract). Gastroenterology 72: 1029, 1977.
 43. Belluzzi, O., O. Sacchi, and E. Wanke. Identification of delayed potassium and calcium currents in the sympathetic neurone under voltage clamp. J. Physiol. Lond. 358: 109–129, 1985.
 44. Benham, C. D., and T. B. Bolton. Patch‐clamp studies of slow potential‐sensitive potassium channels in longitudinal smooth muscle cells of rabbit jejunum. J. Physiol. Lond. 340: 469–486, 1983.
 45. Benham, C. D., T. B. Bolton, and R. J. Lang. Acetylcholine activates an inward current in single mammalian smooth muscle cells. Nature Lond. 316: 345–347, 1985.
 46. Benham, C. D., T. B. Bolton, R. J. Lang, and T. Takewaki. Calcium‐dependent K+‐channels in dispersed intestinal and arterial smooth muscle cells of guinea pigs and rabbits studied by the patch‐clamp technique (Abstract). J. Physiol. Lond. 350: 51P, 1984.
 47. Benham, C. D., T. B. Bolton, R. J. Lang, and T. Takewaki. The mechanism of action of Ba2+ and TEA on single Ca2+‐activated K+‐channels in arterial and intestinal smooth muscle membranes. Pfluegers Arch. 403: 120–127, 1985.
 48. Berridge, M. J. Inositol triphosphate and diacylglycerol as second messengers. Biochem. J. 220: 345–360, 1984.
 49. Bevan, J. A. The connection: Are we ready to throw out the α adrenoceptor in sympathetic vaso‐constriction? Trends Pharmacol. Sci. 5: 53–55, 1984.
 50. Birdsall, N. J. M., A. S. V. Burgen, C. R. Hiley, and E. C. Hulme. Binding of agonists and antagonists to muscarinic receptors. J. Supramol. Struct. 4: 367–371, 1976.
 51. Birdsall, N. J. M., A. S. V. Burgen, and E. C. Hulme. The binding of agonists to brain muscarinic receptors. Mol. Pharmacol. 14: 723–736, 1978.
 52. Birdsall, N. J. M., and E. C. Hulme. Biochemical studies on muscarinic acetylcholine receptors. J. Neurochem. 27: 7–16, 1976.
 53. Birdsall, N. J. M., and E. C. Hulme. Muscarinic receptor subclasses. Trends Pharmacol. Sci. 4: 459–463, 1983.
 54. Bitar, K. N., P. Bradford, J. W. Putney, and G. M. Makhlouf. Cytosolic calcium during contraction of isolated mammalian gastric muscle cells. Science Wash. DC 232: 1143–1145, 1986.
 55. Bitar, K. N., and R. T. Jensen. Binding of 125I‐VIP to isolated gastric smooth muscle cells (Abstract). Gastroenterology 84: 1107, 1983.
 56. Bitar, K. N., and G. M. Makhlouf. Receptors on smooth muscle cells; characterization by contraction and specific antagonists. Am. J. Physiol. 242 (Gastrointest. Liver Physiol. 5): G400–G407, 1982.
 57. Bitar, K. N., and G. M. Makhlouf. Relaxation of isolated gastric smooth muscle cells by vasoactive intestinal peptide. Science Wash. DC 216: 531–532, 1982.
 58. Bitar, K. N., and G. M. Makhlouf. Specific opiate receptors on isolated mammalian gastric smooth muscle cells. Nature Lond. 297: 72–73, 1982.
 59. Bitar, K. N., and G. M. Makhlouf. Measurement of function in isolated single smooth muscle cells. Am. J. Physiol. 250 (Gastrointest. Liver Physiol. 13): G357–G360, 1986.
 60. Bitar, K. N., B. Saffouri, and G. M. Makhlouf. Cholinergic and peptidergic receptors on isolated human antral smooth muscle cells. Gastroenterology 82: 832–837, 1982.
 61. Bitar, K. N., A. M. Zfass, and G. M. Makhlouf. Interaction of acetylcholine and cholecystokinin with dispersed smooth muscle cells. Am. J. Physiol. 237 (Endocrinol. Metab. Gastrointest. Physiol. 6): E172–E176, 1979.
 62. Black, J. L., R. J. French, and E. J. Myleckorane. Receptor mechanisms for 5‐hydroxytryptamine in rabbit arteries. Br. J. Pharmacol. 74: 619–626, 1981.
 63. Black, J. W., D. H. Jenkinson, and T. P. Kenakin. Antagonism of an indirectly acting agonist. Block by propranolol and sotalol of the action of tyramine on rat heart. Eur. J. Pharmacol. 65: 1–10, 1981.
 64. Black, J. W., and P. Leff. Operational models of pharmacological agonism. Proc. R. Soc. Lond. B Biol. Sci. 220: 141–162, 1983.
 65. Black, J. W., P. Leff, and N. Shankley. An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br. J. Pharmacol. 84: 561–571, 1985.
 66. Boeynaems, J. M., and J. E. Dumont. Outlines of Receptor Theory. Amsterdam: Elsevier/North‐Holland, 1980, p. 1–226.
 67. Bolton, T. B. The depolarizing action of acetylcholine or carbachol in intestinal smooth muscle. J. Physiol. Lond. 220: 647–671, 1972.
 68. Bolton, T. B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol. Rev. 59: 606–718, 1979.
 69. Bolton, T. B. Action of acetylcholine on the smooth muscle membrane. In: Smooth Muscle: An Assessment of Current Knowledge, edited by E. Bülbring, A. F. Brading, A. W. Jones, and T. Tomita. London: Arnold, 1981, p. 199–217.
 70. Bornstein, J. C., R. A. North, M. Costa, and J. B. Furness. Excitatory synaptic potentials due to activation of neurons with short projections in the myenteric plexus. Neuroscience 11: 723–731, 1984.
 71. Brading, A. F. Na, Ca and contraction in the smooth muscle of guinea pig taenia coli. In: Excitation‐Contraction Coupling in Smooth Muscle, edited by R. Casteels, T. Godfraind, and J. C. Ruegg. Amsterdam: Elsevier/North‐Holland, 1977, p. 97–99.
 72. Brown, A. M., D. L. Kunze, and A. Yatani. The agonist effect of dihydropyridines on Ca channels. Nature Lond. 311: 570–572, 1984.
 73. Brown, C., G. Burnstock, N. J. Cusack, P. Meghji, and C. J. Moody. Evidence for stereospecificity of the P1 purinoceptor. Br. J. Pharmacol. 75: 101–107, 1982.
 74. Brown, D. A., and P. R. Adams. Muscarinic suppression of a novel voltage‐sensitive K+ current in a vertebrate neurone. Nature Lond. 283: 673–676, 1980.
 75. Brown, D. A., A. Forward, and S. Marsh. Antagonist discrimination between ganglionic and ileal muscarinic receptors. Br. J. Pharmacol. 71: 362–364, 1980.
 76. Bueno, L., J. P. Ferre, J. Fioramonti, and M. Ruckebusch. Control of the antral motor response to feeding by gastric acid secretion in rats. J. Physiol, Lond. 325: 43–50, 1981.
 77. Bueno, L., J. Fioramonti, C. Honde, M. J. Fargeas, and M. P. Primi. Central and peripheral control of gastrointestinal and colonic motility by endogenous opiates in conscious dogs. Gastroenterology 88: 549–556, 1985.
 78. Bülbring, E., and A. Crema. Observations concerning the action of 5‐hydroxytryptamine on the peristaltic reflex. Br. J. Pharmacol. 13: 444–457, 1958.
 79. Bülbring, E., and A. Den Hertog. The action of isoprenaline on the smooth muscle of guinea pig taenia coli. J. Physiol. Lond. 304: 277–296, 1980.
 80. Bülbring, E., and M. D. Gershon. 5‐Hydroxytryptamine participation in the vagal inhibitory innervation of the stomach. J. Physiol. Lond. 192: 832–846, 1968.
 81. Bülbring, E., and J. H. Hardman. Effects on smooth muscle of nucleotides and dibutyryl analogues of cyclic nucleotides. In: Smooth Muscle Pharmacology and Physiology, edited by M. Worcel and G. Vassort. Paris: INSERM, 1976, p. 125–133.
 82. Bülbring, E., and T. Tomita. Calcium requirement for the α‐action of catecholamines on guinea pig taenia coli. Proc. R. Soc. Lond. B Biol. Sci. 197: 271–284, 1977.
 83. Burgen, A. S. V., and L. Spero. The action of acetylcholine and other drugs on the efflux of potassium and rubidium from smooth muscle of the guinea‐pig intestine. Br. J. Pharmacol. 34: 99–115, 1968.
 84. Burks, T. F. Mediation by 5‐hydroxytryptamine in nerve muscle preparations from the guinea pig small intestine and colon. J. Pharmacol. Exp. Ther. 185: 530–539, 1973.
 85. Burleigh, D. E. Evidence for more than one type of 5‐hydroxytryptamine receptor in the human colon. J. Pharm. Pharmacol. 29: 538–541, 1977.
 86. Burnstock, G. Past and current evidence for the purinergic nerve hypothesis. In: Physiological and Regulatory Functions of Adenosine and Adenine Nucleotides, edited by H. P. Baer and G. I. Drummond. New York: Raven, 1979, p. 69–77.
 87. Burnstock, G. The changing face of autonomic neurotransmission. Acta Physiol. Scand. 126: 67–91, 1986.
 88. Burnstock, G., G. Campbell, D. Satchell, and A. Smythe. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non‐adrenergic inhibitory nerves in the gut. Br. J. Pharmacol. 40: 668–688, 1970.
 89. Burnstock, G., T. Cocks, L. Kasakov, and H. K. Wong. Direct evidence for ATP release from non‐adrenergic, non‐cholinergic (purinergic) nerves in the guinea pig taenia coli and bladder. Eur. J. Pharmacol. 49: 145–149, 1978.
 90. Burnstock, G., R. Crowe, C. Kennedy, and J. Torok. Indirect evidence that purinergic modulation of perivascular adrenergic neurotransmission in the portal vein is a physiological process. Br. J. Pharmacol. 82: 359–368, 1984.
 91. Burnstock, G., N. J. Cusack, J. M. Hills, I. MacKenzie, and P. Meghji. Studies on the stereospecificity of the P2 purinoceptor. Br. J. Pharmacol. 79: 907–913, 1983.
 92. Burnstock, G., J. M. Hills, and C. H. V. Hoyle. Evidence that the P1 purinoceptor in the guinea pig taenia coli is an A2 subtype. Br. J. Pharmacol. 81: 533–541, 1984.
 93. Burnstock, G., and C. H. V. Hoyle. PACPX—a substituted xanthine—antagonizes both the A1 and A2 subclasses of the P1 purinoceptor: antagonism of the A2 subclass is competitive but antagonism of the A1 subclass is not. Br. J. Pharmacol. 85: 291–296, 1985.
 94. Caffrey, J. M., J. R. Josephson, and A. M. Brown. Calcium channels of amphibian stomach and mammalian aorta smooth muscle cells. Biophys. J. 49: 1237–1242, 1986.
 95. Casteels, R., L. Raeymaekers, G. Droogmans, and F. Wuytack. Na+‐K+ ATPase, Na‐Ca exchange and excitation‐contraction coupling in smooth muscle. J. Cardiovasc. Pharmacol. 7, Suppl. 3: S103–S110, 1985.
 96. Catterall, W. A. Neurotoxins that act on voltage‐sensitive sodium channels in excitable membranes. Annu. Rev. Pharmacol. Toxicol. 20: 15–43, 1980.
 97. Chow, E., and J. D. Huizinga. Myogenic control activity in longitudinal muscle of human and dog colon. J. Physiol. Lond. 392: 21–34, 1987.
 98. Christensen, J. Pharmacology of the esophageal motor function. Annu. Rev. Pharmacol. 15: 243–258, 1977.
 99. Christensen, J., and E. E. Daniel. Electric and motor effects of autonomic drugs on longitudinal esophageal smooth muscle. Am. J. Physiol. 211: 387–394, 1966.
 100. Christensen, J., and E. E. Daniel. Effects of some autonomic drugs on circular esophageal smooth muscle. J. Pharmacol. Exp. Ther. 159: 243–249, 1968.
 101. Clark, A. J. General pharmacology. In: Handbuch der Experimentellen Pharmakologie, edited by W. Heubner and J. Schueller. Berlin: Springer‐Verlag, 1937, p. 1–228.
 102. Cocks, T. M., and J. A. Angus. Endothelium‐mediated relaxation of coronary arteries by noradrenaline and serotonin. Nature Lond. 305: 627–630, 1983.
 103. Code, C. F., and J. A. Marlett. The interdigestive myoelectric complex of the stomach and small bowel of dogs. J. Physiol. Lond. 246: 289–309, 1975.
 104. Cohen, M. L., and W. E. Colbert. Relationship between receptors mediating serotonin (5‐HT) contractions in the canine basilar artery to 5‐HT1, 5‐HT2 and rat stomach fundus 5‐HT receptors. J. Pharmacol. Exp. Ther. 237: 713–718, 1986.
 105. Cohen, M. L., R. W. Fuller, and K. S. Wiley. Evidence for 5‐HT2 receptors mediating contractions in vascular smooth muscle. J. Pharmacol. Exp. Ther. 218: 421–425, 1981.
 106. Cohen, M. L., N. Mason, K. S. Wiley, and R. W. Fuller. Further evidence that vascular serotonin receptors are of the 5‐HT2 type. Biochem. Pharmacol. 32: 567–570, 1983.
 107. Cohen, M. L., K. W. Schenk, W. Colbert, and G. Wittenauer. Role of 5‐HT2 receptors in serotonin‐induced contractions of non‐vascular smooth muscle. J. Pharmacol. Exp. Ther. 232: 770–774, 1985.
 108. Cohen, M. L., and L. A. Wittenauer. Further evidence that the serotonin receptors in the rat stomach fundus is not 5‐HT1A or 5‐HT1B. Life Sci. 38: 1–5, 1985.
 109. Cohen, M. L., and L. A. Wittenauer. Relationship between serotonin and tryptamine receptors in the rat stomach fundus. J. Pharmacol. Exp. Ther. 233: 75–79, 1985.
 110. Collins, S. M. The muscarinic receptor subtype on gastric isolated muscle cells. In: Muscarinic Receptor Subtypes, edited by G. Lux and E. E. Daniel. Berlin: Springer‐Verlag, 1985, p. 33–36.
 111. Collins, S. M. A comparative study of muscarinic receptor characteristics on canine gastric smooth muscle using isolated cells, muscle strips and plasma membranes (Abstract). Gastroenterology 88: 1353, 1985.
 112. Collins, S. M. Calcium utilization by dispersed canine gastric smooth muscle cells. Am. J. Physiol. 251 (Gastrointest. Liver Physiol. 14): G181–G188, 1986.
 113. Collins, S. M., and D. J. Crankshaw. Dissociation of contraction and muscarinic receptor binding to isolated smooth muscle cells. Am. J. Physiol. 251 (Gastrointest. Liver Physiol. 14): G546–G552, 1986.
 114. Collins, S. M., and J. D. Gardner. Cholecystokinin‐induced contraction of dispersed smooth muscle cells. Am. J. Physiol. 243 (Gastrointest. Liver Physiol. 6): G497–G504, 1982.
 115. Collins, S. M., C. Y. Jung, and A. K. Grover. Muscarinic receptor size on smooth muscle cells and membranes. Am. J. Physiol. 251 (Gastrointest. Liver Physiol. 14): G195–G200, 1986.
 116. Cooke, H. J., M. Montakhab, P. R. Wade, and J. D. Wood. Transmural fluxes of 5‐hydroxytryptamine in guinea pig ileum. Am. J. Physiol. 244 (Gastrointest. Liver Physiol. 7): G421–G425, 1983.
 117. Costa, L. G., B. W. Schwab, H. Hand, and S. D. Murphy. Decreased muscarinic binding sites in small intestine from mice treated with neostigmine. Life Sci. 29: 1675–1682, 1981.
 118. Costa, M., and J. B. Furness. Innvervation of the internal anal sphincter of the guinea pig. In: Proceedings of the 4th International Symposium on Gastrointestinal Motility, edited by E. E. Daniel, J. A. L. Gilbert, B. Schofield, T. K. Schnitka, and G. Scott. Vancouver, Canada: Mitchell, 1974, p. 681–689.
 119. Costa, M., and J. B. Furness. The sites of action of 5‐hydroxytryptamine in nerve muscle preparations from the guinea pig small intestine and colon. Br. J. Pharmacol. 65: 237–248, 1979.
 120. Costa, M., and J. B. Furness. Nervous control of intestinal motility. In: Mediators and Drugs in Gastrointestinal Motility, edited by G. Bertaccini. New York: Springer‐Verlag, 1982, p. 279–382.
 121. Costa, M., J. B. Furness, A. C. Cuello, A. Verhofstad, H. W. M. Steinbush, and R. Elde. Neurons with 5‐hydroxy‐tryptamine like immunoreactivity in the enteric nervous system: their visualization and reactions to drug treatment. Neuroscience 7: 351–363, 1982.
 122. Cox, B., and S. E. Hecker. Investigation of the mechanism of action of oxotremorine on the guinea pig isolated ileum preparation. Br. J. Pharmacol. 41: 19–25, 1971.
 123. Cuthbert, A. W., and J. M. Young. The number of muscarinic receptors in chick amnion muscle. Br. J. Pharmacol. 50: 145–151, 1973.
 124. Dahlof, C. Studies on β adrenoceptor mediated facilitation of sympathetic neurotransmission. Acta Physiol. Scand. Suppl. 500: 1–142, 1981.
 125. Dakhil, T., and W. Vogt. Abhängigkeit der Kontraktion‐swirkung von Phosphatidsaure und Acetylcholin auf die taenia coli vom extracellularen Ionengehalt. Naunyn‐Schmiedebergs Arch. Exp. Pathol. Pharmakol. 251: 344–354, 1965.
 126. Dale, H. H. The action of certain esters and ethers of choline and their relations to muscarine. J. Pharmacol. Exp. Ther. 6: 147–190, 1914.
 127. Daniel, E. E. Further studies of the pharmacology of the pyloric region. Analysis of the effects of intraarterial histamine, serotonin, phenyldiguanide, morphine and other drugs on the antrum and duodenal bulb. Can. J. Physiol. Pharmacol. 44: 981–1019, 1966.
 128. Daniel, E. E. Nonadrenergic, noncholinergic (NANC) neuronal inhibitory interactions with smooth muscle. In: Calcium and Contractility in Smooth Muscle, edited by A. K. Grover and E. E. Daniel. Clifton, NJ: Humana, 1985, p. 385–426.
 129. Daniel, E. E., D. J. Crankshaw, and C. Y. Kwan. Intracellular sources of calcium for activation of smooth muscle. In: Trends in Autonomic Pharmacology, edited by S. Kalsner. Heidelberg, FRG: Urban & Schwarzenberg, 1979, p. 443–484.
 130. Daniel, E. E., J. Crankshaw, and S. Sarna. Prostaglandins and tetrodotoxin‐insensitive relaxation of opossum lower esophageal sphincter. Am. J. Physiol. 236 (Endocrinol. Metab. Gastrointest. Physiol. 5): E153–E172, 1979.
 131. Daniel, E. E., V. P. Daniel, G. Duchon, R. E. Garfield, M. Nichols, S. K. Malhotra, and M. Oki. Is the nexus necessary for cell‐to‐cell coupling in smooth muscle? J. Membr. Biol. 28: 207–239, 1976.
 132. Daniel, E. E., T. Gonda, T. Domoto, M. Oki, and N. Yanaihara. The effects of substance P and met‐enkephalin in dog ileum. Can. J. Physiol. Pharmacol. 60: 830–840, 1982.
 133. Daniel, E. E., A. K. Grover, and C. Y. Kwan. Calcium. In: Biochemistry of Smooth Muscle, edited by N. L. Stephens. Boca Raton, FL: CRC, 1983, p. 1–85.
 134. Daniel, E. E., A. Helmy Elkholy, L. P. Jager, and M. S. Kannan. Neither a purine nor VIP is the mediator of inhibitory nerves of opossum esophageal smooth muscle. J. Physiol. Lond. 336: 243–260, 1983.
 135. Daniel, E. E., J. Jury, and K. H. Robothan. Receptors for neurotransmitters in opossum muscularis mucosa. Br. J. Pharmacol. 88: 707–714, 1986.
 136. Daniel, E. E., and S. K. Sarna. The generation and conduction of activity in smooth muscle. Annu. Rev. Pharmacol. Toxicol. 18: 145–166, 1978.
 137. De Groat, W. C., and J. Krier. The control of the lumbar sympathetic pathway to the large intestine of the cat. J. Physiol. Lond. 289: 449–468, 1979.
 138. Delean, A., J. M. Stadel, and R. J. Lefkowitz. A ternary complex model explains the agonist‐specific binding properties of the adenylate cyclase‐coupled β‐adrenergic receptor. J. Biol. Chem. 255: 7108–7117, 1980.
 139. Den Hertog, A. Calcium and the action of adrenaline, adenosine triphosphate and carbachol on guinea pig taenia caeci. J. Physiol. Lond. 325: 423–439, 1982.
 140. Den Hertog, A., and L. P. Jager. Ion fluxes during the inhibitory junction potential in the guinea pig taenia coli. J. Physiol. Lond. 250: 681–691, 1975.
 141. Den Hertog, A., J. Pielkenrood, R. Ras, and J. Van den Akker. The contribution of calcium and potassium to the α‐action of adrenaline on smooth muscle cells of the portal vein, pulmonary artery and taenia caeci of the guinea pig. Eur. J. Pharmacol. 98: 223–234, 1984.
 142. Diamant, N. E., and T. Y. El‐Sharkawy. Neural control of esophageal peristalsis. Gastroenterology 72: 546–556, 1977.
 143. Diamond, J. Role of cyclic nucleotides in the control of smooth muscle contraction. Adv. Cyclic Nucleotide Res. 9: 327–340, 1978.
 144. Di Marino, A. J., and S. Cohen. The adrenergic control of lower esophageal sphincter function. J. Clin. Invest. 52: 2264–2271, 1973.
 145. Di Marino, A. J., and S. Cohen. The adrenergic control of lower esophageal function. In: Proceedings of the 4th International Symposium on Gastrointestinal Motility, edited by E. E. Daniel, J. A. L. Gilbert, B. Schofield, T. K. Schnitka, and G. Scott. Vancouver, Canada: Mitchell, 1974, p. 623–630.
 146. Dockray, G., and H. Tracy. Atropine‐resistant cephalic stimulation of gastrin release in dogs (Abstract). J. Physiol. Lond. 298: 46P, 1980.
 147. Dodd, J., and J. P. Horn. Muscarinic inhibition of sympathetic C neurones in the bullfrog. J. Physiol. Lond. 334: 271–291, 1983.
 148. Drew, G. M., and S. B. Whiting. Evidence for two distinct types of postsynaptic alpha‐adrenoceptors in vascular smooth muscle in vivo. Br. J. Pharmacol. 67: 207–215, 1979.
 149. Duggan, A. W., and R. A. North. Electrophysiology of opioids. Pharmacol. Rev. 35: 219–281, 1983.
 150. Ehlert, F. J., N. Kokka, and A. S. Fairhurst. Muscarinic receptor subsensitivity in the longitudinal muscle of the rat ileum following chronic anticholinesterase treatment with Di‐isopropylfurophosphate. Biochem. Pharmacol. 29: 1391–1397, 1980.
 151. Ehlert, F. J., W. R. Roeske, L. B. Rosenberger, and H. I. Yamamura. The influence of guanyl‐5′‐yl imidodiphosphate and sodium on muscarinic receptor binding in the rat brain and longitudinal muscle of the rat ileum. Life Sci. 26: 245–252, 1980.
 152. Eisner, D. A., and W. J. Lederer. Na‐Ca exchange: stoichiometry and electrogenicity. Am. J. Physiol. 248 (Cell Physiol. 17): C189–C202, 1985.
 153. Ek, B. A. Studies on mechanisms for β‐adrenoceptor mediated inhibition of colon motility. Acta Physiol. Scand. Suppl. 546: 1–39, 1985.
 154. Ek, B. A., L. A. C. Bjellin, and B. T. Ludgren. β‐Adrenergic control of motility in the rat colon. I. Evidence for functional separation of the β1 and β2 adrenoceptor mediated inhibition of colon activity. Gastroenterology 90: 400–407, 1986.
 155. Ek, B. A., L. A. C. Bjellin, and B. T. Ludgren. β‐Adrenergic control of motility in the rat colon. II. Proportions of β1 and β2 adrenoceptors identified with 125I(—) pindolol binding. Gastroenterology 90: 408–413, 1986.
 156. El‐Fakahany, E. E., and E. Richelson. Phenoxybenzamine and dibenaminal interactions with calcium channel effectors of the muscarinic receptor. Mol. Pharmacol. 20: 519–525, 1981.
 157. El‐Sharkawy, T. Y., and E. E. Daniel. The electrophysiological basis of the motor inhibitory effect of adrenaline on rabbit small intestinal smooth muscle. Can. J. Physiol. Pharmacol. 54: 446–456, 1975.
 158. El‐Sharkawy, T. Y., K. G. Morgan, and J. H. Szurszewski. Intracellular electrical activity of canine and human gastric smooth muscle. J. Physiol. Lond. 279: 291–307, 1978.
 159. Ermisch, A., H. J. Ruhle, R. Landgrad, and J. Hess. Blood‐brain barrier and peptides. J. Cereb. Blood Flow Metab. 5: 350–357, 1985.
 160. Exton, J. H. Mechanisms involved in α‐adrenergic effects of catecholamines. In: Adrenoceptors and Catecholamine Action, edited by G. Kunos. New York: Wiley, 1981, p. 117–129.
 161. Fay, F. S. Isometric contractile properties of single isolated smooth muscle cells. Nature Lond. 265: 553–556, 1977.
 162. Fay, F. S., and C. M. Delise. Contraction of isolated smooth muscle cells. Proc. Natl. Acad. Sci. USA 70: 641–645, 1973.
 163. Fay, F. S., and J. J. Singer. Characteristics of response of isolated smooth muscle cells to cholinergic drugs. Am. J. Physiol. 232 (Cell Physiol. 1): C144–C154, 1977.
 164. Feher, J. J. Mechanism of action of ryanodine on cardiac sarcoplasmic reticulum. Biochim. Biophys. Acta 330: 77–86, 1985.
 165. Feigenbaum, P. P., and E. E. El‐Fakahany. Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: possible involvement in desensitization of receptor function. J. Pharmacol. Exp. Ther. 233: 134–140, 1985.
 166. Ferriera, S. H., A. G. Herman, and J. R. Vane. Prostaglandin production by rabbit isolated jejunum and its relationship to the inherent tone of the preparation. Br. J. Pharmacol. 56: 467–477, 1976.
 167. Fournet, J., W. J. Snape, Jr., and S. Cohen. Modulation of lower esophageal sphincter relaxation in the opossum. Am. J. Physiol. 237 (Endocrinol. Metab. Gastrointest. Physiol. 6): E481–E485, 1979.
 168. Fournet, J., W. J. Snape, Jr., and S. Cohen. Sympathetic control of lower esophageal sphincter function in the cat. J. Clin. Invest. 63: 562–570, 1979.
 169. Fox, J. E. T., S. M. Collins, and E. E. Daniel. Expression of peptide responses depends on study environment. In: Regulatory Peptides in Digestive, Nervous and Endocrine Systems, edited by M. J. M. Lewin and S. Bonfils. Amsterdam: Elsevier, 1985, p. 265–268 (INSERM Symp. no. 25.)
 170. Fox, J. E. T., and E. E. Daniel. Activation of endogenous excitatory opiate pathways in canine small intestine by field stimulation and motilin. Am. J. Physiol. 253 (Gastrointest. Liver Physiol. 16): G189–G194, 1987.
 171. Fox, J. E. T., and E. E. Daniel. Exogenous opiates: their local mechanisms of action in the canine small intestine and stomach. Am. J. Physiol. 253 (Gastrointest. Liver Physiol. 16): G179–G188, 1987.
 172. Fox, J. E. T., E. E. Daniel, J. Jury, A. E. Fox, and S. M. Collins. Sites and mechanisms of action of neuropeptides on canine gastric motility differ in vivo and in vitro. Life Sci. 33: 817–825, 1983.
 173. Fox, J. E. T., E. E. Daniel, J. Jury, and H. Robotham. Muscarinic inhibition of canine small intestinal motility in vivo. Am. J. Physiol. 248 (Gastrointest. Liver Physiol. 11): G526–G531, 1985.
 174. Fox, J. E. T., E. E. Daniel, J. Jury, N. S. Track, and S. Chiu. Cholinergic control of canine antral immunoactive gastrin release and motility. Can. J. Physiol. Pharmacol. 60: 893–901, 1982.
 175. Fox, J. E. T., E. E. Daniel, J. Jury, N. S. Track, and S. Chiu. Cholinergic control mechanisms for immunoreactive motilin release and motility in the canine duodenum. Can. J. Physiol. Pharmacol. 61: 1042–1049, 1983.
 176. Fox, J. E. T., F. Kostolanska, E. E. Daniel, H.‐D. Allescher, and T. Hanke. Mechanisms of excitatory actions of neurotensin on canine small intestinal circular muscle in vivo and in vitro. Can. J. Physiol. Pharmacol. 65: 2254–2259, 1987.
 177. Fox, J. E. T., and T. J. McDonald. Effects of porcine gastrin releasing peptide (GRP) on canine antral motility and gastrin release in vivo. Life Sci. 35: 1415–1422, 1984.
 178. Fox, J. E. T., T. J. McDonald, L. Alford, and F. Kostolanska. Tachykinin activation of muscarinic inhibitory neural pathways in the canine small intestine is SPP in nature. Life Sci. 39: 1123–1128, 1986.
 179. Frechner, B., and C. Euler. Influence of pudendal block on the function of the anal sphincters. Gut 16: 482–489, 1975.
 180. Frew, R., and P. M. Lundy. Effect of arylazido aminopropionyl ATP (ANAPP3), a putative ATP antagonist, on ATP responses of isolated guinea pig smooth muscle. Life Sci. 30: 259–267, 1982.
 181. Friedman, M. E., G. Suarez‐Kurtz, G. J. Kaczorowski, G. M. Katz, and J. P. Reuben. Two calcium currents in a smooth muscle cell line. Am. J. Physiol. 250 (Heart Circ. Physiol. 19): H699–H703, 1986.
 182. Fuder, H., H. Kilbinger, and H. Miller. Organ selectivity of hexahydrosiladifenidol in blocking pre‐ and post‐functional muscarinic receptors studied in guinea pig ileum and rat heart. Eur. J. Pharmacol. 113: 125–127, 1985.
 183. Fujiwara, M., S. Hong, and I. Muramatsu. Effects of Goniopora toxin on non‐adrenergic non‐cholinergic response and purine nucleotide release in guinea pig taenia coli. J. Physiol. Lond. 326: 515–526, 1982.
 184. Furchgott, R. F. The use of beta‐halo‐alkylamines in the differentiation of receptors and the determination of dissociation constants of receptor‐agonist complexes. Adv. Drug Res. 3: 21–51, 1966.
 185. Furchgott, R. F. The classification of adrenoceptors. An evaluation from the standpoint of receptor theory. In: Catecholamines Handbuch der Experimentellen Pharmakologie, edited by H. Blaschko and E. Muscholl. Berlin: Springer‐Verlag, 1972, vol. 33, p. 283–335.
 186. Furchgott, R. F., and P. Bursztyn. Comparison of dissociation constants and of relative efficacies of selective agonists acting on parasympathetic receptors. Ann. NY Acad. Sci. 144: 882–899, 1967.
 187. Furness, J. B., and M. Costa. The adrenergic innervation of gastrointestinal tract. Ergeb. Physiol. Biol. Chem. Exp. Pharmacol. 69: 1–51, 1974.
 188. Furness, J. B., and M. Costa. Identification of gastrointestinal transmitters. In: Handbook of Experimental Pharmacology. Mediators and Drugs in Gastrointestinal Motility I. Morphological Basis and Neurophysiological Control, edited by G. Bertaccini. Berlin: Springer‐Verlag, 1982, vol. 59, pt. 1, p. 383–962.
 189. Furness, J. B., and M. Costa. Neurons with 5‐hydroxytrypt‐amine like immunoreactivity in the enteric nervous system: their projections in the guinea pig small intestine. Neuroscience 4: 305–310, 1982.
 190. Gabella, G. Innervation of the gastrointestinal tract. Int. Rev. Cytol. 59: 130–193, 1982.
 191. Gabo, G., L. Barbara, G. A. Lanfranchi, M. Bortolotti, and M. Miglioli. Modification of the electrical activity of the human intestine after serotonin and caerulein. Dig. Dis. Sci. 17: 363–372, 1972.
 192. Gaginella, T. S., T. J. Rimele, and T. M. O'Dorisio. Muscarinic receptors in the human pyloric sphincter: comparison with other species. Gen. Pharmacol. 12: 93–96, 1981.
 193. Gaginella, T. S., T. J. Rimele, T. M. O'Dorisio, and R. J. Dorff. Pharmacologic identification of muscarinic receptors in the pylorus of the cat by binding of [3H]quinuclidinyl benzilate. Life Sci. 26: 1599–1608, 1980.
 194. Galper, J. B., and T. W. Smith. Agonist and guanine nucleotide modulation of muscarinic cholinergic receptors in cultured heart cells. J. Biol. Chem. 255: 9571–9579, 1980.
 195. Gerner, T. Pressure responses to OP‐CCK compared to CCK‐PZ in the antrum and fundus of isolated guinea pig stomachs. Scand. J. Gastroenterol. 14: 73–77, 1979.
 196. Gerner, T., and J. F. W. Haffner. Interactions of cholecystokinin (CCK‐PZ) and gastrin on motor activity of isolated guinea pig antrum and fundus. Scand. J. Gastroenterol. 13: 789–794, 1978.
 197. Gerschenfeld, H. M., and D. Paupardan‐Tritch. Ionic mechanisms and receptor properties underlying the responses of molluscan neurones to 5‐hydroxytryptamine. J. Physiol. Lond. 243: 427–456, 1974.
 198. Gershon, M. D., R. G. Robinson, and L. L. Ross. Serotonin accumulation in the guinea pig myenteric plexus: ion dependency, structure activity relationship and the effect of drugs. J. Pharmacol. Exp. Ther. 198: 548–561, 1976.
 199. Gershon, M. D., M. Takaki, H. Tamir, and T. Branchnek. The enteric neural receptor for 5‐hydroxytryptamine. Experientia 41: 863–868, 1985.
 200. Gilbert, R., S. Rattan, and R. K. Goyal. Pharmacologic identification, activation and antagonism of two muscarinic receptor subtypes in the lower esophageal sphincter. J. Pharmacol. Exp. Ther. 230: 284–291, 1984.
 201. Gillespie, J. S., and M. A. Khoyi. The site and receptors responsible for the inhibition by sympathetic nerves of intestinal smooth muscle and its parasympathetic motor nerves. J. Physiol. Lond. 267: 767–789, 1977.
 202. Gilman, A. G. G proteins and dual control of adenylate cyclase. Cell 36: 577–579, 1984.
 203. Godfraind, T., and R. C. Miller. Mechanisms of smooth muscle relaxation. In: Calcium and Contractility in Smooth Muscle, edited by A. K. Grover and E. E. Daniel. Clifton, NJ: Humana, 1985, p. 93–117.
 204. Goldberg, L. T., P. H. Volkman, and J. D. Koihli. A comparison of the vascular dopamine receptor with other dopamine receptors. Annu. Rev. Pharmacol. Toxicol. 18: 57–79, 1978.
 205. Goyal, R. K., and B. W. Cobb. Motility of the pharynx, esophagus and esophageal sphincters. In: Physiology of the Gastrointestinal Tract (1st ed.), edited by L. R. Johnson. New York: Raven, 1981, p. 359–389.
 206. Goyal, R. K., and S. Rattan. Nature of vagal inhibitory innervation to the lower esophageal sphincter. J. Clin. Invest. 55: 1119–1126, 1975.
 207. Goyal, R. K., and S. Rattan. Neurohumeral, hormonal and drug receptors for the lower esophageal sphincter. Gastroenterology 74: 598–619, 1978.
 208. Graff, G., J. Stephenson, D. Glass, M. Haddox, and N. Goldberg. Activation of soluble splenic cell guanylate cyclase by prostaglandin endoperoxidase and fatty acid hydroperoxides. J. Biol. Chem. 253: 7662–7676, 1978.
 209. Graham, M. F., R. F. Diegelman, C. O. Elson, K. N. Bitar, and H. P. Ehrlich. Isolation and culture of human intestinal smooth muscle cells. Proc. Soc. Exp. Biol. Med. 176: 503–507, 1984.
 210. Grover, A. K. Calcium‐handling studies using isolated smooth muscle membranes. In: Calcium and Contractility in Smooth Muscle, edited by A. K. Grover and E. E. Daniel. Clifton, NJ: Humana, 1985, p. 245–269.
 211. Grover, A. K., J. Crankshaw, R. E. Garfield, and E. E. Daniel. Smooth muscle membrane vesicle orientation: a study on intactness and sidedness of rat myometrium plasma membrane. Can. J. Physiol. Pharmacol. 58: 1202–1211, 1980.
 212. Grover, A. K., C. Y. Kwan, J. Crankshaw, D. J. Crankshaw, R. E. Garfield, and E. E. Daniel. Characteristics of Ca transport and binding by rat myometrium plasma membrane subfractions. Am. J. Physiol. 239 (Cell Physiol. 8): C66–C74, 1980.
 213. Grover, A. K., C. Y. Kwan, and E. E. Daniel. Ca2+ dependence of calcium uptake by rat myometrium plasma membrane‐enriched fraction. Am. J. Physiol. 242 (Cell Physiol. 11): C278–C282, 1982.
 214. Grover, A. K., C. Y. Kwan, P. K. Rangachari, and E. E. Daniel. Na‐Ca exchange in a smooth muscle plasma membrane‐enriched fraction. Am. J. Physiol. 244 (Cell Physiol. 13): C158–C165, 1983.
 215. Grundy, D., and T. Scratchard. The role of the vagus and sympathetic nerves in the control of gastric motility. In: Gastric and Gastroduodenal Motility, edited by L. M. A. Akkermans, A. G. Johnson, and N. W. Read. New York: Praeger, 1984, p. 21–33.
 216. Gupta, S. K., J. F. Moran, and D. J. Triggle. Mechanism of action of benzilylcholine mustard at the muscarinic receptor. Mol. Pharmacol. 12: 1019–1026, 1976.
 217. Haefely, W. E. Non‐nicotinic chemical stimulation of automatic ganglia. In: Pharmacology of Ganglionic Transmission, edited by D. A. Kharkevich. Berlin: Springer‐Verlag, 1980, p. 313–357.
 218. Hammer, R., C. P. Berrie, N. J. M. Birdsall, A. S. V. Burgen, and E. C. Hulme. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature Lond. 283: 90–92, 1980.
 219. Hammer, R., and A. Giachetti. Selective muscarinic antagonists. Trends Pharmacol. Sci. 5: 18–20, 1984.
 220. Hardman, J. G. Cyclic nucleotides and smooth muscle contractions: some conceptual and experimental considerations. In: Smooth Muscle: An Assessment of Current Knowledge, edited by E. Bülbring, A. F. Brading, A. W. Jones, and T. Tomita. London: Arnold, 1981, p. 249–262.
 221. Hartzell, H. C., S. W. Kuffler, R. Stickgobl, and D. Yoshikami. Synaptic excitation and inhibition resulting from direct action of acetylcholine on two types of chemoreceptors on individual amphibian parasympathetic neurones. J. Physiol. Lond. 271: 817–846, 1977.
 222. Henderson, R. M., G. Duchon, and E. E. Daniel. Cell contacts in duodenal smooth muscle layers. Am. J. Physiol. 221: 564–574, 1971.
 223. Hess, P., J. B. Lansman, and R. W. Tsien. Different modes of Ca channel gating behaviour favoured by dehydropyridine Ca agonists and antagonists. Nature Lond. 311: 538–544, 1984.
 224. Hirst, G. D. S., M. E. Holman, and I. Spence. Two types of neurones in the myenteric plexus of the duodenum of the guinea pig. J. Physiol. Lond. 236: 303–326, 1974.
 225. Hirst, G. D. S., and E. M. Silinski. Some effects of 5‐HT dopamine and noradrenaline on neurones in the submucous plexus. J. Physiol. Lond. 251: 817–832, 1975.
 226. Hogaboom, C. A., and J. S. Fedan. Calmodulin stimulation of calcium uptake and (Ca2+‐Mg2+)‐ATPase activities in microsomes from canine tracheal smooth muscle. Biochem. Biophys. Res. Commun. 99: 737–744, 1981.
 227. Hollenberg, M. D. Examples of homospecific and heterospecific receptor regulators. Trends Pharmacol. Sci. 6: 242–245, 1985.
 228. Holzer, P., F. Lembeck, and J. Donner. Caerulein, substance P, serotonin and cholinomimetics induce rhythmic contractions of the intestinal circular muscle. Naunyn‐Schmiedeberg's Arch. Pharmacol. 312: 131–137, 1980.
 229. Honeyman, T., P. Merriam, and F. S. Fay. The effects of isoproterenol on adenosine cyclic 3′, 5′, monophosphate and contractility in isolated smooth muscle cells. Mol. Pharmacol. 14: 86–98, 1978.
 230. Hughes, I. E., and D. MaCkay. Quantification of the characteristics of antagonists exhibiting both competitive antagonism and functional interaction. Br. J. Pharmacol. 85: 271–275, 1985.
 231. Huizinga, J. D. Intestinal Motility: Regulatory Function of Adenosine and Adenosine Triphosphate. Groningen, The Netherlands: Univ. of Groningen, 1981. PhD thesis.
 232. Huizinga, J. D. Electrophysiology of human colon motility in health and disease. Clin. Gastroenterol. 15: 879–901, 1986.
 233. Huizinga, J. D., and A. Den Hertog. Inhibition of fundic strips from guinea pig stomach: the effect of theophylline on responses to adenosine, ATP and intramural nerve stimulation. Eur. J. Pharmacol. 63: 259–265, 1980.
 234. Huizinga, J. D., J. M. Pielkenrood, and A. Den Hertog. Dual action of high energy adenine nucleotides in comparison with responses evoked by other adenine derivatives and intra‐mural nerve stimulation on smooth muscle. Eur. J. Pharmacol. 74: 175–180, 1981.
 235. Huizinga, J. D., H. S. Stern, N. E. Diamant, and T. Y. El‐Sharkawy. Electrophysiological basis of excitation and inhibition in the human colon. Gastroenterology 90: 1197–1207, 1986.
 236. Humphrey, P. P. A. Peripheral 5‐hydroxtryptamine receptors and their classification. Neuropharmacology 23: 1503–1510, 1984.
 237. Hunter, R., R. A. Haworth, and H. A. Berkoff. Modulation of cellular calcium stores in the perfused rat heart by isoproterenol and ryanodine. Circ. Res. 53: 703–712, 1983.
 238. Isaacs, P. E. T., J. S. Whitehead, and Y. S. Kim. Muscarinic acetylcholine receptors of the small intestine and pancreas of the rat; distribution and effect of vagotomy. Clin. Sci. Lond. 62: 203–207, 1982.
 239. Isenberg, G. Cardiac purkinje fibers. Cesium as a tool to block inward‐rectifying potassium currents. Pfluegers Arch. 365: 99–106, 1976.
 240. Jaffe, B. M., A. Ferrera, and D. J. Sherlock. Comparative effects of ketanserin, atropine and methylsergide on the gastrointestinal effects of hyperserotoninemia in the awake dog. J. Pharmacol. Exp. Ther. 238: 536–541, 1986.
 241. Jafferi, S. S., and R. H. Michell. Muscarinic cholinergic stimulation of phosphatidylinositol turnover in longitudinal smooth muscle of guinea pig ileum. Biochem. J. 154: 653–657, 1976.
 242. Jager, L. P. The effects of catecholamines and ATP on the smooth muscle cell membrane of the guinea pig taenia coli. Eur. J. Pharmacol. 25: 372–382, 1974.
 243. Jansson, G., and J. Martinson. Studies on the ganglionic site of action of sympathetic outflow to the stomach. Acta Physiol. Scand. 68: 184–192, 1966.
 244. Jenden, D. J., and A. S. Fairhurst. The pharmacology of ryanodine. Pharmacol. Rev. 21: 1–25, 1969.
 245. Johns, A., and D. M. Paton. Effect of indomethacin on atropine resistant transmission in rabbit and monkey urinary bladder: evidence for involvement of prostaglandins in transmission. Prostaglandins 13: 245–254, 1977.
 246. Johnson, S. M., Y. Katayama, and R. A. North. Multiple actions of 5‐hydroxytryptamine on myenteric neurones of the guinea pig ileum. J. Physiol. Lond. 304: 459–470, 1980.
 247. Jones, L. M., S. Cockcroft, and R. H. Michell. Stimulation of phosphatidylinositol turnover in various tissues by cholinergic and adrenergic agonists, by histamine and caerulea. Biochem. J. 182: 669–676, 1979.
 248. Jury, J., L. P. Jager, and E. E. Daniel. Unusual potassium channels mediate NANC‐nerve mediated inhibition in opossum esophagus. Can. J. Physiol. Pharmacol. 63: 107–112, 1985.
 249. Kamikawa, Y., K. Serizawa, and Y. Shimo. Some possibilities for prostaglandin mediation in the contractile response to ATP of the guinea pig digestive tract. Eur. J. Pharmacol. 45: 199–203, 1977.
 250. Katz, A. M. Effects of digitalis on cell biochemistry: sodium pump inhibition. J. Am. Coll. Cardiol. 5, Suppl. A: 16A–21A, 1985.
 251. Kellum, J. M., R. J. Maxwell, J. Potter, and J. F. Kummerle. Motilin's induction of phasic contractile activity in canine jejunum is mediated by luminal release of serotonin. Surgery St. Louis 100: 445–453, 1986.
 252. Kenakin, T. P. Receptor classification by selective agonists: coping with circularity and circumstantial evidence. Trends Pharmacol. Sci. 4: 291–295, 1983.
 253. Kenakin, T. P. The classification of drugs and drug receptors in isolated tissues. Pharmacol. Rev. 36: 165–222, 1984.
 254. Kenakin, T. P., and D. Beck. Is prenalterol (H133/80) really a selective β1‐adrenoceptor agonist? Tissue selectively resulting from differences in stimulus‐response relationship. J. Pharmacol. Exp. Ther. 213: 406–413, 1980.
 255. Kent, R. S., A. De Lean, and R. J. Lefkowitz. A quantitative analysis of β‐adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modelling of ligand binding data. Mol. Pharmacol. 17: 14–23, 1980.
 256. Kilbinger, H. Facilitation and inhibition by muscarinic agonists of acetylcholine release from guinea pig myenteric neurones: mediation through different types of neuronal muscarine receptors. Trends Pharmacol. Sci. 5: 49–52, 1984.
 257. Kilbinger, H. Presynaptic muscarine receptors modulating acetylcholine release. Trends Pharmacol. Sci. 5: 103–105, 1984.
 258. Kilbinger, H., S. Halim, G. Lambrecht, W. Weiler, and I. Wessler. Comparison of affinities of muscarinic antagonists to pre‐ and postjunctional receptors in the guinea pig ileum. Eur. J. Pharmacol. 103: 313–320, 1984.
 259. Kilbinger, H., R. Kruel, I. Pfeuffer‐Friederich, and I. Wessler. The effects of metoclopromide on acetylcholine release and on smooth muscle response in isolated guinea pig ileum. Naunyn‐Schmiedeberg's Arch. Pharmacol. 319: 231–238, 1982.
 260. Kilbinger, H., and M. Nafziger. Two types of neuronal muscarine receptors modulating acetylcholine release from guinea pig myenteric plexus. Naunyn‐Schmiedeberg's Arch. Pharmacol. 328: 304–309, 1985.
 261. Kilbinger, H., and I. Wessler. Pre‐ and postsynaptic effects of muscarinic agonists in the guinea pig ileum. Naunyn‐Schmiedeberg's Arch. Pharmacol. 314: 259–266, 1980.
 262. Klein, W. L., N. Natanson, and M. Nirenberg. Muscarinic receptor regulation by accelerated rate of receptor loss. Biochem. Biophys. Res. Commun. 90: 506–512, 1979.
 263. Konturek, S. J., P. Thor, R. Król, A. Dembiński, and A. V. Schally. Influence of methionine‐enkephalin and morphine on myoelectric activity of small bowel. Am. J. Physiol. 238 (Gastrointest. Liver Physiol. 1): G384–G389, 1980.
 264. Kosterlitz, H. W., and G. M. Lees. Pharmacological analysis of intrinsic intestinal reflexes. Pharmacol. Rev. 16: 301–339, 1964.
 265. Kosterlitz, H. W., and J. A. Robinson. Inhibition of the peristaltic reflex of the isolated guinea pig ileum. J. Physiol. Lond. 136: 249–262, 1957.
 266. Kreulen, D. L., and J. H. Szurszewski. Nerve pathways in celiac plexus of the guinea pig. Am. J. Physiol. 237 (Endocrinol. Metab. Gastrointest. Physiol. 6): E90–E97, 1979.
 267. Kreulen, D. L., and J. H. Szurszewski. Reflex pathways in the abdominal prevertebral ganglia: evidence for a colocolonic inhibitory reflex. J. Physiol. Lond. 295: 21–32, 1979.
 268. Kroeger, E. A., and J. M. Marshall. Beta‐adrenergic effects on rat myometrium: mechanisms of membrane hyper‐polarization. Am. J. Physiol. 225: 1339–1345, 1973.
 269. Kubota, M., and J. H. Szurszewski. Innervation of the canine internal anal sphincter (Abstract). Gastroenterology 86: 1146, 1984.
 270. Kunos, G., B. Hoffman, N. Kwook, W. H. Kan, and L. Mucci. Dihydroergocryptine binding and α‐adrenoceptors in smooth muscle. Nature Lond. 278: 254–256, 1979.
 271. Kwan, C. Y., P. Kostka, A. K. Grover, J. S. Law, and E. E. Daniel. Calmodulin stimulation of plasmalemmal Ca2+‐pump of canine aortic smooth muscle. Blood Vessels 23: 22–23, 1986.
 272. Laduron, P. Criteria for receptor sites in binding studies. Biochem. Pharmacol. 33: 833–839, 1984.
 273. Lambrecht, G., U. Moser, E. Mutschler, J. Weiss, H. Linoh, M. Strecker, and R. Tacke. Hexahydrosiladifenidol; a selective antagonist on ileal muscarinic receptors (Abstract). Naunyn‐Schmiedeberg's Arch. Pharmacol. 325: R62, 1984.
 274. Lands, A. M., A. Arnold, J. P. McAuliff, F. P. Luduena, and T. G. Brown. Differentiation of receptor systems activated by sympathemimetric amines. Nature Lond. 214: 597–598, 1967.
 275. Langer, S. Z. Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 23: 1793–1800, 1974.
 276. Langer, S. Z. Presynaptic receptors and their role in the regulation of transmitter release. Br. J. Pharmacol. 60: 481–497, 1977.
 277. Lassignal, N. L., J. J. Singer, and J. V. Walsh, Jr. Multiple neuropeptides exert a direct effect on the same isolated single smooth muscle cell. Am. J. Physiol. 250 (Cell Physiol. 19): C792–C798, 1986.
 278. Lee, T. P., J. F. Kuo, and P. Greencard. Role of muscarinic cholinergic receptors in regulation of guanosine 3′,5′ cyclic monophosphate content in mammalian brain, heart muscle and intestinal smooth muscle. Proc. Natl. Acad. Sci. USA 69: 3287–3291, 1972.
 279. Lees, G. M. A hitchhiker's guide to the galaxy of adrenoceptors. Br. Med. J. 283: 173–178, 1981.
 280. Leff, P., G. R. Martin, and J. M. Morse. Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants. Br. J. Pharmacol. 85: 655–663, 1985.
 281. Lemberger, H. F., N. Mason, and M. L. Cohen. 5‐HT receptors in the rat portal vein. Desensitization following cumulative serotonin addition. Life Sci. 35: 71–77, 1984.
 282. Leoitzki, A. Receptor to effector coupling in the receptor‐dependent adenylate cyclase system. J. Recept. Res. 4: 399–409, 1984.
 283. Leysen, J. E. Serotoninergic receptors in brain tissue. Properties and identification of various 3H‐ligand binding sites in vitro. J. Physiol. Paris 77: 351–362, 1982.
 284. Leysen, J. E., C. J. E. Niemsgeers, J. M. Van Nueten, and M. Laduron. [3H]ketanserin (R41468) a selective [3H]‐ligand for serotonin2 receptor binding sites. Binding properties, brain distribution and functional role. Mol. Pharmacol. 21: 301–314, 1982.
 285. Litosch, I., and J. N. Fain. Phosphatidylinositol turnover and Ca2+ gating. In: Phospholipids and Cellular Regulation, edited by J. F. Kuo. Boca Raton, FL: CRC, 1985, vol. 1, p. 159–179.
 286. Lundberg, J. M., B. Hedlund, and T. Bartfai. Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland. Nature Lond. 295: 147–148, 1982.
 287. Lyrenas, E. β‐Adrenergic Influence on Esophageal and Colonic Motility in Man. Göteborg, Sweden: Univ. of Göteborg, 1985. PhD thesis.
 288. Lyrenas, E., H. Abrahamsson, and G. Dotevall. Rectosigmoid motility response to β‐adrenoceptor stimulation in patients with irritable bowel syndrome. Scand. J. Gastroenterol. 20: 1163–1168, 1985.
 289. Lyrenas, E., H. Abrahamsson, and G. Dotevall. Effects of β‐adrenoceptor stimulation on rectosigmoid motility in man. Dig. Dis. Sci. 30: 536–540, 1985.
 290. Maas, A. J. J., and A. Den Hertog. The effect of the phenylphosphatase N‐0164 on prostaglandin action and on postinhibitory excitation in the taenia of guinea pig caecum. Eur. J. Pharmacol. 62: 157–166, 1980.
 291. Maas, A. J. J., A. Den Hertog, R. Ras, and J. Van den Akker. The action of apamin on guinea pig taenia caeci. Eur. J. Pharmacol. 67: 265–274, 1980.
 292. MaCkay, D. An analysis of functional antagonism and synergism. Br. J. Pharmacol. 73: 127–136, 1981.
 293. Malik, K. U. Prostaglandins‐modulation of adrenergic nervous system. Federation Proc. 37: 203–207, 1978.
 294. Manber, L., and M. D. Gershon. A reciprocal adrenergic‐cholinergic axoaxonic synapse in the mammalian gut. Am. J. Physiol. 236 (Endocrinol. Metab. Gastrointest. Physiol. 5): E738–E745, 1979.
 295. Mangel, A. Voltage and receptor mediated contractile activity of colonic smooth muscle in calcium free solution. Eur. J. Pharmacol. 102: 165–168, 1984.
 296. Martin, W., R. F. Furchgott, G. M. Villani, and D. Jothranadan. Depression of contractile responses in rat aorta by spontaneously released endothelium‐derived relaxing factor. J. Pharmacol. Exp. Ther. 237: 529–539, 1986.
 297. Maton, P. N., V. E. Sutcliff, Z.‐C. Zhou, J. D. Garner, and R. T. Jenson. Characterization of receptors for calcitonin‐gene‐related peptide GRP on gastric smooth muscle cells (Abstract). Gastroenterology 90: 1537, 1986.
 298. Matsumoto, K., S. Uchida, K. Takeyasu, H. Higuchi, and H. Yoshida. The effects of trypsin‐treatment on agonist binding affinity to the muscarinic acetylcholine receptor. Life Sci. 31: 211–220, 1982.
 299. May, D. C., E. M. Ross, A. G. Gilman, and M. D. Smigel. Reconstitution of catecholamine‐stimulated adenylate cyclase using three purified proteins. J. Biol. Chem. 260: 15829–15833, 1985.
 300. Mayhan, W. G., and D. D. Heistad. Permeability of blood‐brain barrier to various sized molecules. Am. J. Physiol. 248 (Heart Circ. Physiol. 17): H712–H718, 1985.
 301. Mckinney, M., and E. Richelson. The coupling of the neuronal muscarinic receptor to response. Annu. Rev. Pharmacol. Toxicol. 24: 121–146, 1984.
 302. McLean, J., and J. E. Fox. Mechanisms of action of neurotensin on motility of canine gastric corpus in vitro. Can. J Physiol. Pharmacol. 61: 29–34, 1983.
 303. Mcpherson, G. A. A practical computer based approach to the analysis of radioligand binding experiments. Comput. Programs Biomed. 17: 107–114, 1983.
 304. Meisheri, K. D., J. C. Ruegg, and R. J. Paul. Studies on skinned fiber preparations. In: Calcium and Contractility in Smooth Muscle, edited by A. K. Grover and E. E. Daniel. Clifton, NJ: Humana, 1985, p. 191–224.
 305. Meisheri, K. D., and C. Van Breemen. Effects of β‐adrenergic stimulation on calcium movement on rabbit aortic smooth muscle relationship with cyclic AMP. J. Physiol. Lond. 331: 429–441, 1982.
 306. Mian, M. A., E. Malta, and C. Raper. An homogenous population of β1 adrenoceptors subserves inhibitory responses in guinea pig ileum preparations. J. Pharm. Pharmacol. 36: 698–699, 1984.
 307. Michell, R. H. Inositol phospholipids and cell surface receptor function. Biochim. Biophys. Acta 415: 81–147, 1975.
 308. Minneman, K. P., and P. W. Abel. “Spare” alpha1‐adrenergic receptors and the potency of agonists in rat vas deferens. Mol. Pharmacol. 25: 56–63, 1984.
 309. Misiewicz, J., S. L. Waller, and M. Eisner. Motor responses of human gastrointestinal tract to 5‐hydroxytrypta‐mine in vivo and in vitro. Gut 7: 208–216, 1966.
 310. Moody, C. J., and G. Burnstock. Evidence for the presence of P1 purinoceptors on cholinergic nerve terminals in the guinea pig ileum. Eur. J. Pharmacol. 11: 1–9, 1982.
 311. Morgan, K. G., P. F. Schmalz, and J. H. Szurszewski. The inhibitory effects of VIP on mechanical and electrical activity of canine antral smooth muscle. J. Physiol. Lond. 282: 437–450, 1978.
 312. Morita, K., and R. A. North. Clonidine activates membrane potassium conductance in myenteric neurones. Br. J. Pharmacol. 74: 419–428, 1981.
 313. Morita, K., R. A. North, and T. Tokimasa. Muscarinic agonists inactivate potassium conductance of guinea pig myenteric neurons. J. Physiol. Lond. 333: 125–139, 1982.
 314. Morita, K., R. A. North, and T. Tokimasa. Muscarinic presynaptic inhibition of synaptic transmission in myenteric plexus of guinea pig ileum. J. Physiol. Lond. 333: 141–149, 1982.
 315. Morton, I. K. M., and J. Halliday. Adrenoceptors in smooth muscle. In: Adrenoceptors and Catecholamine Action, edited by G. Kunos. New York: Wiley, 1981, p. 1–68.
 316. Motulsky, H. J., and L. C. MaHan. The kinetics of competitive radiological binding predicted by the law of mass action. Mol. Pharmacol. 25: 1–9, 1984.
 317. Motulsky, H. J., L. C. Mahan, and P. A. Insel. False premises: radioligand, agonists and membrane receptors on intact cells: data analysis in a bind. Trends Pharmacol. Sci. 6: 317–319, 1985.
 318. Müller, M. J., and H. P. Baer. Apamin, a non‐specific antagonist of smooth muscle relaxant. Naunyn‐Schmiedeberg's Arch. Pharmacol. 311: 105–107, 1980.
 319. Müller, M. J., and D. M. Paton. Presynaptic inhibitory actions of 2 substituted adenosine derivatives on neurotransmission in rat vas deferens, effects of inhibitors of adenosine uptake and deamination. Naunyn‐Schmiedeberg's Arch. Pharmacol. 306: 23–28, 1979.
 320. Munson, P. J., and D. Rodbard. LIGAND: a versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 107: 220–239, 1980.
 321. Narducci, F., G. Bassotti, and S. Daniotti. Identification of muscarinic receptor subtype mediating colonic response to eating. Dig. Dis. Sci. 30: 124–128, 1985.
 322. Nishizuka, Y. Studies and perspectives of protein kinase C. Science Wash. DC 233: 305–312, 1986.
 323. North, R. A., and T. M. Egan. Electrophysiology of peptides in the peripheral nervous system. Br. Med. Bull. 38: 291–296, 1982.
 324. North, R. A., G. Henderson, Y. Katayama, and S. M. Johnson. Electrophysiological evidence for presynaptic inhibition of acetylcholine release by 5‐hydroxytryptamine in the enteric nervous system. Neuroscience 5: 581–586, 1980.
 325. North, R. A., and A. Surprenant. Inhibitory synaptic potentials resulting from α2 adrenoceptor activities in guinea pig submucous plexus neurones. J. Physiol. Lond. 358: 17–34, 1985.
 326. North, R. A., and A. Surprenant. Muscarinic M1 and M2 receptors mediate depolarization and presynaptic inhibition in guinea‐pig enteric nervous system. J. Physiol. Lond. 368: 435–452, 1985.
 327. North, R. A., and T. Tokimasa. Depression of calcium‐dependent potassium conductance of guinea‐pig myenteric neurones by muscarinic agonists. J. Physiol. Lond. 333: 151–156, 1982.
 328. North, R. A., and T. Tokimasa. Muscarinic synaptic potentials in guinea‐pig myenteric plexus neurones. J. Physiol. Lond. 342: 253–266, 1983.
 329. Northup, J. K., M. D. Smigel, P. C. Sternweis, and A. G. Gilman. The subunits of the stimulatory regulatory component of adenylate cyclase: resolution of the activated 45,000‐dalton (α) subunit. J. Biol. Chem. 258: 11368–11376, 1983.
 330. Northup, J. K., P. C. Sternweis, and A. G. Gilman. The subunits of the stimulatory regulatory component of adenylate cyclase: resolution activity and properties of the 35,000‐dalton (β) subunit. J. Biol. Chem. 258: 11361–11367, 1983.
 331. Ochillo, R. F., C. S. Tsai, and M. H. Tsai. Mechanism of action of muscarine on the longitudinal muscle of the guinea‐pig isolated ileum. Br. J. Pharmacol. 72: 225–232, 1981.
 332. O'Donnell, S. R., and J. C. Wanstall. The use of functional antagonism to determine whether β‐adrenoreceptor agonists must have a lower efficacy than isoprenaline to be trachea‐atria selective in vitro in guinea pig. Br. J. Pharmacol. 60: 255–262, 1977.
 333. Ohrn, P. G., and L. Rentzhog. Effects of adrenergic blockade on gastrointestinal propulsion after laparotomy. Acta Chir. Scand. 461: 51–64, 1976.
 334. Okwuasaba, F. K., J. T. Hamilton, and M. A. Cook. Relaxations of guinea pig fundic strip by adenosine, adenine nucleotides and electrical stimulation: antagonism by theophylline and desensitization to adenosine and derivatives. Eur. J. Pharmacol. 46: 181–198, 1977.
 335. Ormsbee, H. S., D. A. Silber, and F. E. Hard, Jr. Serotonin regulation of the canine migrating motor complex. J. Pharmacol. Exp. Ther. 231: 436–440, 1984.
 336. Palacios, J. M. Receptor autoradiography: the last ten years. J. Recept. Res. 4: 633–644, 1984.
 337. Parks, A. G., D. J. Fishlock, J. D. H. Cameron, and H. May. Preliminary investigations of the pharmacology of the human internal anal sphincter. Gut 10: 674–679, 1969.
 338. Paton, D. M. Presynaptic inhibition of adrenergic neurotransmission by adenine nucleotides and adenosine. In: Physiological and Regulatory Functions of Adenosine and Adenine Nucleotides, edited by H. P. Baer and G. I. Drummond. New York: Raven, 1979, p. 69–77.
 339. Paton, W. D. M., and E. S. Vizi. The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea‐pig ileum longitudinal muscle strip. Br. J. Pharmacol. 35: 10–28, 1969.
 340. Pedigo, N., H. I. Yamamura, and D. L. Nelson. Discrimination of multiple [3H]‐5‐hydroxydopamine binding sites by the neuroleptic spiperone in rat brain. J. Neurochem. 36: 220–226, 1981.
 341. Pernow, B. Substance P. Pharmacol. Rev. 35: 85–131, 1983.
 342. Peroutka, S. J., and S. H. Snyder. Multiple serotonin receptors: differential binding of [3H]‐5‐hydroxytryptamine, [3H]‐lysergicacid diethylamide and [3H]‐spiroperidol. Mol. Pharmacol. 16: 687–699, 1979.
 343. Petersen, O. H., and Y. Maraiyama. Calcium‐activated potassium channels and their role in secretion. Nature Lond. 307: 693–696, 1984.
 344. Pirola, C. J., M. S. Balda, S. Finkielman, and V. E. Nahmod. Increase in muscarinic receptors in rat intestine by thyrotropin releasing hormone (TRH). Life Sci. 34: 1643–1649, 1984.
 345. Pitts, B. J. R. Stoichiometry of Na‐Ca exchange in cardiac sarcolemmal vesicles. J. Biol. Chem. 254: 6232–6235, 1979.
 346. Porzig, H. Are there differences in the β receptor‐adenylate cyclase systems of fragmented membranes and living cells? Trends Pharmacol. Sci. 3: 75–78, 1982.
 347. Pressman, B. C. Properties of ionophores with broad range of cation selectivity. Federation Proc. 32: 1698–1710, 1973.
 348. Pruitt, D. B., M. N. Grubb, D. C. Jagnette, and T. F. Burks. Intestinal effects of 5‐HT and morphine in guinea pigs, dogs, cats and monkeys. Eur. J. Pharmacol. 26: 298–305, 1974.
 349. Rand, M. J., M. W. McCulloch, and D. F. Story. Prejunctional modulation of noradrenaline transmission by noradrenaline dopamine and acetylcholine. In: Central Action of Drugs in Blood Pressure Regulation, edited by D. S. Davies and J. L. Reid. London: Pitman, 1975, p. 94–132.
 350. Rattan, S., and R. K. Goyal. Neural control of the lower esophageal sphincter: influence of vagus nerves. J. Clin. Invest. 54: 899–906, 1974.
 351. Rattan, S., and R. K. Goyal. Effects of 5‐hydroxytryptamine on the lower esophageal sphincter in vivo: evidence for multiple sites of action. J. Clin. Invest. 59: 125–133, 1977.
 352. Rayner, V. Characterization of the internal anal sphincter and the rectum of the velvet monkey. J. Physiol. Lond. 286: 383–399, 1979.
 353. Reed, P. W. Biochemical and biological effects of carboxylic acid ionophores. In: Polyether Antibiotics: Naturally Occurring Acid Ionophores, edited by J. W. Westly. New York: Dekker, 1980, vol. 1, p. 185–302.
 354. Reeves, J. P., and J. L. Sutko. Na‐Ca exchange generates a current in cardiac membrane vesicles. Science Wash. DC 208: 1461–1464, 1980.
 355. Rimele, T. J., W. A. Rogers, and T. S. Gaginella. Characterization of muscarinic cholinergic receptors in the lower esophageal sphincter of the cat: binding of [3H]quinuclidinyl benzilate. Gastroenterology 77: 1225–1234, 1979.
 356. Rokaeus, A. Studies on neurotensin as a hormone: assay and release of neurotensin‐like immunoreactivity and effects of neurotensin. Acta Physiol. Scand. Suppl. 501: 5–62, 1981.
 357. Roman, C. Nervous control of esophageal and gastric motility. In: Gastric and Gastroduodenal Motility, edited by L. M. A. Akkermans, A. G. Johnson, and N. W. Read. New York: Praeger, 1984, p. 21–40.
 358. Roman, C., and J. Gonella. Extrinsic control of digestive tract motility. In: Physiology of the Gastrointestinal Tract (1st ed.), edited by L. R. Johnson. New York: Raven, 1981, p. 289–333.
 359. Ross, E. M., and A. G. Gilman. Biochemical properties of hormone‐sensitive adenylate cyclase. Annu. Rev. Biochem. 49: 533–564, 1980.
 360. Roszkowski, A. P. An unusual type of sympathetic ganglionic stimulant. J. Pharmacol. Exp. Ther. 132: 156–170, 1961.
 361. Ruckebusch, Y., and L. Bueno. Electrical activity of ovine jejunum and changes due to disturbances. Am. J. Dig. Dis. 20: 1027–1034, 1975.
 362. Rupfolo, R. R. Stereoselectivity in adrenergic agonists and adrenergic blocking agents. In: Stereochemistry and Biological Activity of Drugs, edited by E. J. Ariens, W. Sardyn, and W. Timmermans. Oxford, UK: Blackwell, 1983, p. 103–125.
 363. Sakai, Y., E. E. Daniel, J. Jury, and J. E. T. Fox. Neurotensin inhibition of canine intestinal motility in vivo via α‐adrenoceptors. Can. J. Physiol. Pharmacol. 62: 403–411, 1984.
 364. Salmon, D. M. W., and T. W. Honeyman. Increased phosphatidate accumulation during single contractions of isolated smooth‐muscle cells. Biochem. Soc. Trans. 7: 986–988, 1979.
 365. Salmon, D. M. W., and T. W. Honeyman. Proposed mechanism of cholinergic action in smooth muscle. Nature Land. 824: 344–345, 1980.
 366. Sanders, K. M. Evidence that prostaglandins are local regulatory agents in canine ileal circular muscle. Am. J. Physiol. 246 (Gastrointest. Liver Physiol. 9): G361–G371, 1984.
 367. Sanders, K. M. Role of prostaglandins in regulating gastric motility. Am. J. Physiol. 247 (Gastrointest. Liver Physiol. 10): G117–G126, 1984.
 368. Sarna, S., P. Northcott, and L. Belbeck. Mechanism of cycling of migrating myoelectric complexes: effect of morphine. Am. J. Physiol. 242 (Gastrointest. Liver Physiol. 5): G588–G595, 1982.
 369. Sawynok, J., and K. Jhamandas. Inhibition of acetylcholine from cholinergic nerves by adenosine, adenine nucleotides and morphine: antagonism by theophylline. J. Pharmacol. Exp. Ther. 197: 379–390, 1976.
 370. Sawynok, J., and K. Jhamandas. Muscarinic feedback inhibition of acetylcholine release from the myenteric plexus in the guinea pig ileum, and its status after chronic exposure to morphine. Can. J. Physiol. Pharmacol. 55: 909–916, 1977.
 371. Scheid, C. R., and F. S. Fay. β‐Adrenergic stimulation of 42K influx in isolated smooth muscle cells. Am. J. Physiol. 246 (Cell Physiol. 15): C415–C421, 1984.
 372. Scheid, C. R., and F. S. Fay. β‐Adrenergic effects on transmembrane 45Ca fluxes in isolated smooth muscle cells. Am. J. Physiol. 246 (Cell Physiol. 15): C431–C438, 1984.
 373. Scheid, C. R., T. W. Honeyman, and F. S. Fay. Mechanism of β‐adrenergic relaxation of smooth muscle. Nature Lond. 277: 32–36, 1979.
 374. Schemann, M., and H. J. Ehrlein. Effects of neurohormonal agents on jejunal contraction spread and transit in the fed dog. Gastroenterology 90: 1950–1955, 1986.
 375. Schotte, A., J. E. Leysen, and P. M. Laduron. Evidence for a displaceable non‐specific [3H]neurotensin binding site in rat brain. Naunyn‐Schmiedeberg's Arch. Pharmacol. 333: 400–405, 1986.
 376. Schultz, G., J. G. Hardman, K. Schultz, K. C. E. Baird, and E. W. Sutherland. The importance of calcium ions for the regulation of guanosine 3′: 5′‐cyclic monophosphate levels. Proc. Natl. Acad. Sci. USA 70: 3889–3893, 1973.
 377. Seamon, K. B., and J. W. Daly. Forskolin, a unique diterpene activator of cyclic AMP generating systems. J. Cyclic Nucleotide Res. 7: 201–224, 1981.
 378. Seidel, E. R., and L. R. Johnson. 15‐Leu (125I) gastrin binding and gastrin (G‐17) induced contraction in isolated guinea pig gastric fundus smooth muscle cells (Abstract). Gastroenterology 82: 1175, 1982.
 379. Seidel, E. R., and L. R. Johnson. Contraction and [3H]‐QNB binding in collagenase isolated fundic smooth muscle cells. Am. J. Physiol. 245 (Gastrointest. Liver Physiol. 8): G270–G276, 1983.
 380. Seidel, E. R., T. A. Miller, and L. R. Johnson. Distribution of (3H)QNB binding in dog gastric smooth muscle pre‐ and postvagotomy. Life Sci. 31: 749–756, 1982.
 381. Sekar, M. C., and B. D. Roufogalis. Muscarinic‐receptor stimulation enhances polyphosphoinositide breakdown in guinea pig ileum smooth muscle. Biochem. J. 223: 527–531, 1984.
 382. Shuba, M. F., N. G. Kochemasova, and V. M. Taranenko. O sopriazhenii vozbuzhdeniia‐sokrashcheniia v gladkomy‐shechnykh klethakh vorotnoi veny pri deistvii noradrenalina. Fiziol. Zh. SSSR IM I M Sechenova 68: 1143–1150, 1982.
 383. Shuba, M. F., and I. A. Vladimirova. Effect of apamin on the electrical responses of smooth muscle to adenosine 5′‐triphosphate and to non‐adrenergic, non‐cholinergic nerve stimulation. Neuroscience 5: 853–859, 1980.
 384. Siegel, H., and D. J. Triggle. Benzilcholine mustard and spare receptors in guinea pig ileum. Life Sci. 30: 1645–1652, 1982.
 385. Silensky, E. M. The biophysical pharmacology of calcium‐dependent acetylcholine secretion. Pharmacol. Rev. 37: 81–132, 1985.
 386. Sills, M. A., B. B. Wolffe, and A. Frazer. Determination of selective and non‐selective compounds for the 5‐HT1A and 5‐HT1B receptor subtype in rat frontal cortex. J. Pharmacol. Exp. Ther. 231: 480–487, 1984.
 387. Sims, S. M., J. J. Singer, and J. V. Walsh, Jr. Cholinergic agonists suppress a potassium current in freshly dissociated smooth muscle cells of the toad. J. Physiol. Lond. 367: 503–529, 1985.
 388. Singer, J. J., and F. S. Fay. Detection of contraction of isolated smooth muscle cells in suspension. Am. J. Physiol. 232 (Cell Physiol. 1): C138–C143, 1977.
 389. Singer, J. J., and J. V. Walsh, Jr. Large conductance Ca2+‐activated K+ channels in smooth muscle cell membrane. Reduction in unitary currents due to internal Na+ ions. Biophys. J. 45: 68–70, 1984.
 390. Sjöquist, A., B. Hallerback, and H. Glise. Reflex adrenergic inhibition of colonic motility in anesthetized rat caused by nociceptive stimuli of peritoneum. An α2‐adrenoceptor mediated response. Dig. Dis. Sci. 30: 749–754, 1985.
 391. Sklar, L. A., V. M. Mcneil, and D. A. Finney. Competitive binding kinetics in ligand‐receptor systems. Theoretical and experimental approaches (Abstract). Circulation 68: IIIF, 1983.
 392. Skok, V. I. Ganglionic transmission morphology and physiology. In: Pharmacology of Ganglionic Transmission, edited by D. A. Kharkevich. Berlin: Springer‐Verlag, 1980, p. 1–39.
 393. Sladeczek, F., J. Bockaert, and J. P. Mauger. Differences between agonist and antagonist binding to alpha‐adrenergic receptors of intact and broken‐cell preparations. Mol. Pharmacol. 24: 392–397, 1983.
 394. Small, R. C., and A. H. Weston. Intramural inhibition in rabbit and guinea pig intestine. In: Physiological and Regulatory Functions of Adenosine and Adenine Nucleotides, edited by H. P. Baer and G. I. Drummond. New York: Raven, 1979, p. 45–61.
 395. Smigel, M. D., K. M. Ferguson, and A. G. Gilman. Control of adenylate cyclase activity by G proteins. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 19: 103–111, 1985.
 396. Sneddon, P., and G. Burnstock. Inhibition of excitatory junction potentials in guinea pig vas deferens by α‐β‐methylene ATP: further evidence for ATP and noradrenaline as cotransmitters. Eur. J. Pharmacol. 100: 85–90, 1984.
 397. Sneddon, P., L. A. Meldrum, and G. Burnstock. Control of transmitter release in guinea pig vas deferens by prejunctional P1 purinoreceptors. Eur. J. Pharmacol. 105: 293–299, 1984.
 398. Soll, A. H. Fundic mucosal muscarinic receptors modulating gastric acid secretion. Trends Pharmacol. Sci. 5 Suppl.: 60–62, 1984.
 399. Souquet, J. C., K. N. Bitar, and G. M. Makhlouf. Binding of radioiodinated substance P and substance K to isolated intestinal smooth muscle cells. Gastroenterology 88: 1595, 1985.
 400. Souquet, J. C., J. R. Grider, K. N. Bitar, and G. M. Makhlouf. Receptors for mammalian tachykinins on isolated smooth muscle cells. Am. J. Physiol. 249 (Gastrointest. Liver Physiol. 12): G533–G538, 1985.
 401. Stephenson, R. P. A modification of receptor theory. Br. J. Pharmacol. Chemother. 11: 379–393, 1956.
 402. Stern, S., J. Castenfors, S. J. Berg, T. Sjöberg, K. E. Andersson, and L. Norgren. Effects of α adrenoceptor subtype selective antagonists on the human saphenous vein in vivo. Acta Physiol. Scand. 126: 15–19, 1986.
 403. Stiles, G. L., M. G. Caron, and R. J. Lefkowitz. β‐Adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol. Rev. 64: 661–743, 1984.
 404. Stjärne, L., and P. Astrand. Relative pre‐ and post‐junctional roles of noradrenaline and adenosine 5′‐triphosphate as neurotransmitters of the sympathetic nerves of guinea pig and mouse vas deferens. Neuroscience 14: 929–946, 1985.
 405. Su, C., J. A. Bevan, and G. Burnstock. 3H‐adenosine triphosphate: release during stimulation of enteric nerves. Science Wash. DC 173: 336–338, 1971.
 406. Suematsu, E., M. Hirata, and H. Kuriyama. Effects of cAMP and cGMP dependent protein kinases on Ca2+‐uptake by highly purified sarcolemmal vesicles of vascular smooth muscle. Biochim. Biophys. Acta 773: 83–90, 1984.
 407. Surprenant, A., and R. A. North. k‐Opioid receptors and α2‐adrenoceptors coexist on myenteric but not on submucous neurones. Neuroscience 16: 425–430, 1985.
 408. Sutko, J. L., and J. J. Kenyon. Ryanodine modification of cardiac muscle responses to potassium‐free solutions. Evidence for inhibition of sarcoplasmic reticulum calcium release. J. Gen. Physiol. 82: 385–404, 1983.
 409. Szelenyi, I. Does pirenzepine distinguish between “subtypes” of muscarinic receptors? Br. J. Pharmacol. 77: 567–569, 1982.
 410. Szerb, J. C. Endogenous acetylcholine release and labelled acetylcholine formation for [3H]‐choline in the myenteric plexus of the guinea pig ileum. Can. J. Physiol. Pharmacol. 53: 566–574, 1975.
 411. Szurszewski, J. H. Electrophysiological basis for gastrointestinal motility. In: Physiology of the Gastrointestinal Tract (1st ed.), edited by L. R. Johnson. New York: Raven, 1981, p. 1435–1466.
 412. Szurszewski, J. H., and W. A. Weems. A study of peripheral input to and its control by postganglionic neurones on the inferior mesenteric ganglion. J. Physiol. Lond. 256: 541–556, 1976.
 413. Takayanagi, I., K. Okumura, and K. Koike. Interaction of muscarinic drugs with their receptor. Gen. Pharmacol. 16: 269–272, 1985.
 414. Takeyasu, K., S. Uchida, R. T. Lai, H. Higuchi, Y. Nouchi, and H. Yoshida. Regulation of muscarinic acetylcholine receptors and contractility of guinea pig vas deferens. Life Sci. 28: 527–531, 1981.
 415. Takeyasu, K., S. Uchida, A. Wada, M. Maruno, R. T. Lai, F. Hata, and H. Yoshida. Experimental evidence and dynamic aspects of spare receptor. Life Sci. 25: 1761–1772, 1979.
 416. Taylor, I. K., A. W. Cuthbert, and J. M. Young. Muscarinic receptors in rat intestinal muscle: comparison with the guinea pig. Eur. J. Pharmacol. 31: 319–326, 1975.
 417. Tomita, T., and H. Watanabe. A comparison of the effects of adenosine triphosphate with noradrenaline and with the inhibitory potential of the guinea pig taenia coli. J. Physiol. Lond. 231: 167–177, 1973.
 418. Tonini, M., L. Onori, S. Lecchini, G. M. Frigo, E. Perucca, P. Saltarelli, and A. Crema. 5‐HT mediated GABA excitatory responses in the guinea pig proximal ileum. Naunyn‐Schmiedeberg's Arch. Pharmacol. 324: 180–184, 1983.
 419. Trachte, G. J. The influence of prostaglandins on neurotransmission in the rabbit isolated vas deferens. Prostaglandins 29: 47–59, 1985.
 420. Triggle, D. J., and R. A. Janis. Calcium antagonists and ionophores. In: Calcium and Contractility in Smooth Muscle, edited by A. K. Grover and E. E. Daniel. Clifton, NJ: Humana, 1985, p. 37–60.
 421. Tsien, R. W. Calcium channels in excitable cell membranes. Annu. Rev. Physiol. 45: 341–358, 1983.
 422. Turner, R. S., and J. F. Kuo. Phospholipid‐sensitive Ca2+ dependent protein kinase (protein kinase C): the enzyme, substrate and regulation. In: Phospholipids and Cellular Regulation, edited by J. F. Kuo. Boca Raton, FL: CRC, 1985, vol. 1, p. 75–110.
 423. Uchida, S., K. Matsumoto, K. Takeyasu, H. Higuchi, and H. Yoshida. Molecular mechanisms of the effect of guanine nucleotide and sulfhydryl reagent on muscarinic receptors in smooth muscles studies by radiation inactivation. Life Sci. 31: 201–209, 1982.
 424. Ucki, S., E. Okasmoto, K. Kuwata, A. Toyosaka, K. Nagai, S. Uchida, and H. Yoshida. Increase in muscarinic acetylcholine receptors in mouse intestine by hexamethonium treatment. Life Sci. 32: 2431–2437, 1983.
 425. Ulvestad, A., and T. Gerner. Effects of α‐ and β‐adrenergic agents and dopamine on gastric motor activity stimulated by acetylcholine or physostigmine. Scand. J. Gastroenterol. Suppl. 89: 59–64, 1984.
 426. U'Prichard, D. C. Direct binding studies of α‐adrenoceptors. In: Adrenoceptors and Catecholamine Action, edited by G. Kunos. New York: Wiley, 1981, p. 131–179.
 427. Van Breemen, C., P. Aaronson, and R. Loutzenhiser. Na‐Ca interactions in mammalian smooth muscle. Pharmacol. Rev. 30: 167–208, 1979.
 428. Van Calker, D., M. Müller, and B. Hamprecht. Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33: 995–1005, 1979.
 429. Van Den Brink, F. G. The model of functional interaction. II. Experimental verification of a new model: the antagonism of β‐adrenoceptor stimulants and other agonists. Eur. J. Pharmacol. 22: 279–286, 1973.
 430. Van Nueten, J. M. Comparison of isotonic and isometric measurements in isolated arterial tissues. In: Vascular Neuroeffector Mechanisms, edited by J. A. Bevan, T. Godfraind, R. A. Maxwell, and A. N. Vanhatte. New York: Raven, 1980, p. 37–39.
 431. Van Nueten, J. M., J. E. Leysen, P. M. Van Houtte, and P. A. J. Janssen. Serotoninergic responses in vascular and nonvascular tissues. Arch. Int. Pharmacodyn. Ther. 256: 331–334, 1982.
 432. Vermillion, D. L., R. Scicchitano, and S. M. Collins. Immunomodulation of motility: antigen‐specific contraction of smooth muscle from sensitized rats (Abstract). Gastroenterology In press.
 433. Verplanken, P. A., R. A. Lefebvre, and M. G. Bogaert. Pharmacological characterization of α‐adrenoceptors in the rat gastric fundus. J. Pharmacol. Exp. Ther. 231: 404–410, 1984.
 434. Volle, R. L. Ganglionic actions of anticholinesterase agents, catecholamines, neuro‐muscular blocking agents and local anesthetics. In: Pharmacology of Ganglionic Transmission, edited by D. A. Kharkevich. Berlin: Springer‐Verlag, 1980, p. 385–410.
 435. Wallis, D. I., and R. A. North. Intracellular recording of responses of rabbit superior cervical ganglia cells to 5‐hydroxytryptamine applied by iontophoresis. Neuropharmacology 17: 1023–1028, 1978.
 436. Walsh, J. V., Jr., and J. J. Singer. Penetration‐induced hyperpolarization as evidence for Ca2+ activation of K+ conductance in isolated smooth muscle cells. Am. J. Physiol. 239 (Cell Physiol. 8): C182–C189, 1980.
 437. Walsh, J. V., Jr., and J. J. Singer. Voltage clamp of single freshly dissociated smooth muscle cells: current‐voltage relationships for three currents. Pfluegers Arch. 390: 207–210, 1981.
 438. Walsh, J. V., Jr., and J. J. Singer. Ca2+‐activated K+ channels in vertebrate smooth muscle cells. Cell Calcium 4: 321–330, 1983.
 439. Ward, D., and J. M. Young. Ligand binding to muscarinic receptors in intact longitudinal muscle strips from guinea‐pig intestine. Br. J. Pharmacol. 61: 189–197, 1977.
 440. Warshaw, D. M., J. L. Szarek, M. S. Hubbard, and J. N. Evans. Pharmacology and force development of single freshly isolated bovine carotid artery smooth muscle cells. Circ. Res. 58: 399–406, 1986.
 441. Watanabe, A. M., M. M. McConnaughey, R. A. Strawbridge, J. W. Fleming, L. R. Jones, and H. R. Besch, Jr. Muscarinic cholinergic receptor modulation of β‐adrenergic receptor affinity for catecholamines. J. Biol. Chem. 4833–4836, 1978.
 442. Waud, D. R. Pharmacological receptors. Pharmacol. Rev. 20: 49–88, 1968.
 443. Weiner, N., and P. Taylor. Drugs acting at synaptic and neuroeffector junctional sites. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, edited by A. G. Gilman, L. S. Goodman, R. W. Raw, and F. Murad. New York: MacMillan, 1985, p. 66–99.
 444. Weston, A. H. The effect of desensitization to adenosine triphosphate on the peristaltic reflex in guinea pig ileum. Br. J. Pharmacol. 47: 606–608, 1973.
 445. Wikberg, J. E. S. The pharmacological classification of adrenergic α1‐ and α2‐receptors and their mechanism of action. Acta Physiol. Scand. Suppl. 468: 1–99, 1979.
 446. Willens, J. L., W. A. Buylaert, R. A. Lefebvre, and M. G. Bogaert. Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal tract. Pharmacol. Rev. 37: 165–216, 1985.
 447. Williams, D. A., and F. S. Fay. Calcium transients and resting levels in isolated smooth muscle cells as monitored with quin 2. Am. J. Physiol. 250 (Cell Physiol. 19): C779–C791, 1986.
 448. Williamson, J. R., R. H. Cooper, S. K. Joseph, and A. P. Thomas. Inositol trisphosphate and diacylglycerol as intracellular second messengers in liver. Am. J. Physiol. 248 (Cell Physiol. 17): C203–C216, 1985.
 449. Wood, J. D., and C. J. Mayer. Serotonergic activation of tonic type enteric neurons in the guinea pig small bowel. J. Neurophysiol. 42: 582–593, 1979.
 450. Wood, J. D., and C. J. Mayer. Adrenergic inhibition of serotonin release from neurones in guinea pig Auerbach's plexus. J. Neurophysiol. 42: 594–603, 1979.
 451. Wuytack, R., G. De Schutter, and R. Casteels. Partial purification of Ca‐Mg‐dependent ATPase from pig smooth muscle and reconstitution of ATP‐dependent, Ca‐transport system. Biochem. J. 198: 65–271, 1981.
 452. Yagasaki, O., H. Funaki, and I. Yanagiya. Contribution of endogenous prostaglandins to excitation of the myenteric plexus of guinea pig ileum: are adrenergic factors involved? Eur. J. Pharmacol. 103: 1–8, 1984.
 453. Yamura, H. I., and S. M. Snyder. Biochemical characterization of muscarinic cholinergic receptors in the longitudinal muscle of the guinea pig ileum with [3H]quinuclidinyl benzilate. Mol. Pharmacol. 10: 861–867, 1974.
 454. Yoshino, M., and H. Yabu. Single Ca channel currents in mammalian visceral smooth muscle cells. Pfluegers Arch. 404: 285–286, 1985.
 455. Zlokovic, B. V., D. J. Bigley, and D. G. Chain‐Eliash. Blood‐brain barrier permeability to leucine‐enkephalin, d‐alanine, 2‐d‐leucine 5‐enkephalin and their N‐terminal aminoacid (tyrosine). Brain Res. 336: 125–132, 1985.

Contact Editor

Submit a note to the editor about this article by filling in the form below.

* Required Field

Article Title: Pharmacology of drugs acting on gastrointestinal motility
 

How to Cite

Edwin E. Daniel, Stephen M. Collins, Jo‐Ann E. T. Fox, Jan D. Huizinga. Pharmacology of drugs acting on gastrointestinal motility. Compr Physiol 2011, Supplement 16: Handbook of Physiology, The Gastrointestinal System, Motility and Circulation: 715-757. First published in print 1989. doi: 10.1002/cphy.cp060119